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Integrões de class 1, disseminação de genes de resistência aos 
antibióticos, bactérias de Gram-negativo, ambiente hospitalar. 
 
 
Actualmente, é cada vez mais frequente a associação de bactérias 
oportunistas e comensais resistentes a antibióticos com infecções 
nosocomiais. Este problema clínico tornou-se preocupante e deve-se 
ao uso indiscriminado de antibióticos. Perante esta pressão selectiva, 
as bactérias desenvolvem diferentes mecanismos de resistência a estes 
compostos. A presença de estruturas capazes de transportar genes de 
resistência, designadas por integrões, que contribuem para a 
disseminação destes genes bem como a sua associação com o perfil de 
resistência de bactérias constitui o objectivo do presente trabalho.  
Assim, foram recolhidas amostras de superfícies das instalações 
sanitárias, do serviço de Medicina II, do Hospital Infante D. Pedro, 
Aveiro. Após o isolamento das bactérias em meio selectivo para Gram-
negativas (MacKonkey), todos os isolados foram sujeitos a tipagem 
molecular por BOX-PCR. O perfil de bandas obtido após electroforese 
foi analisado com o programa GelCompar II software (Applied Maths, 
Kortrijk, Belgium), permitindo distinguir diferentes grupos clonais. De 
cada grupo clonal foi seleccionado um isolado para os estudos 
posteriores, resultando num total de 45 isolados distintos. 
A pesquisa de integrões classe 1 iniciou-se por um “screening” para o 
gene da integrase. Nos 25 isolados positivos para este gene, foi 
amplificada e caracterizada a respectiva região variável. A sequência 
nucleotídica dos amplicões foi comparada com outras depositadas na 
base de dados. 
Os resultados mostraram a presença de integrões em diferentes 
espécies (Pseudomonas putida, Klebsiella pneumoniae, Escherichia coli, 
Pseudomonas mendocina, Proteus mirabillis e Morganella morganii). 
As regiões variáveis apresentavam diferentes tamanhos e diferentes 
arranjos de genes. Em geral, predominam gene cassettes que 
conferem resistência aos aminoglicosídeos, trimetoprime e metalo-β-
lactamases. A localização destas estruturas no genoma bacteriano foi 
efectuada por “southern blot”; o DNA genómico foi digerido com a 
enzima S1, e sujeito a hibridação com sondas para os genes 16S e da 
integrase revelando que a maioria dos integrões estão localizados em 
plasmídeos. 
Como conclusão geral, verifica-se a prevalência de isolados contendo 
determinantes genéticos de resistência em superfícies inanimadas do 
ambiente hospitalar (53.33%), os quais podem constituir um potencial 
risco para os pacientes, uma vez que se trata de bactérias oportunistas. 
O facto de estes genes de resistência estarem associados a elementos 
genéticos móveis, nomeadamente transposões e muitas vezes 
plasmídeos, facilita a sua disseminação no ambiente hospitalar, 
principalmente por transferência horizontal de genes. 
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Currently, it is becoming frequent the association of antibiotic 
resistant opportunistic and commensal bacteria with nosocomial 
infections. This is a clinical problem of concern and is based on the 
indiscriminate use of antibiotics. Given the selective pressure within 
the hospital environment, bacteria develop different resistance 
mechanisms to these compounds. The presence of structures, 
referred as integrons, that carry and disseminate these resistance 
genes among bacteria and their association with the bacteria 
resistance profile constitutes the aim of the present study.  
To this end we collected samples from surfaces of sanitary facilities, 
of the Medicine II service of the Hospital Infante D. Pedro, Aveiro. 
After bacteria isolation on a selective medium  (MacKonkey) for 
Gram negatives, all the isolates were  molecular typed by BOX-PCR. 
After electrophoresis, the banding pattern was analysed with the 
GelCompar II software (Applied Maths, Kortrijk, Belgium), which 
allowed for the selection of different clonal groups. One isolate was 
selected from each group for further studies.  
Forty five isolates were selected for the screening of class 1 
integrons. In the twenty-five positive isolates respective variable 
region was amplified and characterized. Amplicons  nucleotide 
sequences were compared with others deposited in databases.  
The results revealed the presence of integrons in different species 
(Pseudomonas putida, Klebsiella pneumoniae, Escherichia coli, 
Pseudomonas mendocina, Proteus mirabillis e Morganella 
morganii). Different lenghts of variable regions and different genes 
arrays were found. Generally gene cassettes conferring resistance to 
aminoglycosides trimethoprim and metallo-β-lactamases were 
predominante. Southern hybridization of S1 digested genomic DNA 
with 16 rDNA and integrase genes labeled probes  revealed that the 
majority of the integrons are located in plasmids.  
To conclude, is important to refer that there is a prevalence of 
opportunistic bacteria possessing integrons in inanimate surfaces 
within the hospital environment, which can constitute risk to the 
debilitated patients. Moreover, these structures are associated with 
mobile genetic elements, mainly transposons and many times 
plasmids, which facilitates the dissemination of these antibiotic 
resistance genes in the hospital environment,  mainly by horizontal 
gene transfer. 
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1. ANTIBIOTICS  
 
Simple microorganisms such as bacteria, appeared on our planet about 3.5 billion 
years ago, and had to adapt to the inhospitable conditions of that time, in order to 
survive. Several studies have concluded that these microorganisms have a remarkable 
ability to adapt and proliferate in any environment, no matter how harsh it is (Bennett 
2008).  
 
In the 30´s, Alexander Fleming discovered a new solution that came to end with the 
pain and death caused by many diseases. This was based on the natural and spontaneous 
production of an antibacterial compound – penicillin, produced by a fungus, Penicillium 
spp., marking the beginning  of the antibiotic era and antimicrobial chemotherapy (Ruiz 
2003; Abeylath and Turos 2008). It started to be used in 1940 to treat infections caused 
by Staphylococcus aureus (Smith and Romesberg 2007; Yamaguchi 2009). 
 
The euphoria triggered by the discovery continued over the next two decades, where 
new classes of antibiotics were discovered and introduced as shown in Figure 1. Most of 
these antibiotic compounds were of natural origin, since they were produced by 
microorganisms, such as bacteria and fungi, but nowadays a big part of the compounds 
are of synthetic origin (Levy and Marshall 2004). 
 
It was really a breakthrough in the field of medicine (Clewell 2005), since these 
compounds were only toxic to the bacterial cell, because the target of the antibiotic is 
absent in the host cell (B. Henriques Normark 2002), and some experts believed that 
infectious diseases would be conquered (JM Conly 2005). But in reality that did not 
happened and the initial optimism was lost (Smith and Romesberg 2007; Yamaguchi 
2009), being necessary to discover new solutions for this problem. 
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Figure 1 - Chronological order of the development of the main classes of antibiotics (adopted 
from (JM Conly 2005).  
 
 
 
1.1 Modes of action of the different classes of antibiotics 
 
The antibiotics can be classified according to their action, spectrum of activity and 
chemical structure (Table 1). Antibiotics of the same class have a similar toxicity and 
spectra of activity (Tenover 2006). 
Some classes of antibiotics can act on the bacterial cell, inhibiting their growth or 
reproduction - bacteriostatic antibiotics; while others may act on the bacterial cell leading 
to death - bactericidal antibiotics. 
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Antibiotics can act only against a limited variety of bacterial species – narrow-
spectrum antibiotics, or can be effective against a wide range of pathogens of different 
species – broad-spectrum antibiotics (Clewell 2005; Murray 2009). 
 
The bacterial sensitivity depend of selective toxicity of the antibiotic and varies 
between different bacterial species and strains within the same bacterial population (B. 
Henriques Normark 2002). 
 
The antibiotic activity can be measured in vitro by determining the minimal inhibitory 
concentration (MIC). For a reliable result of the tests, one must work with a standardized 
methodology, which is currently recommended by the Clinical Laboratory Standards 
Institute, formerly National Committee for Clinical Laboratory Standards (NCCLS). The 
procedures to determine the inhibitory activity can be performed by broth dilution or 
agar techniques. The antibiotic agents are usually tested in successive dilutions, and the 
lowest concentration able to inhibit the growth of an organism is considered as the MIC 
(CLSI 2006).  
 
The mode of action of most antibiotics is well known, and is generally similar in 
antibiotics of the same group, giving rise to a pattern of cross-resistance. Knowledge of 
these mechanisms is important to understand the basis of the combined action of the 
antibiotics, since a synergistic effect only occurs when there is a pattern in the 
combination and they have different sites of action (Mc Dermott, Walker et al. 2003) 
 
Thus, there are four mains modes of action distributed for all classes of antibiotics, 
which are efficacious against different Gram-negative bacteria species, as summarized in 
Table 1. 
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i. Disruption of cell wall due to ligation between the β-lactam antibiotics and 
penicillin binding proteins (PBPs), present in cell wall, inhibiting the 
peptidoglycan synthesis (Mc Dermott, Walker et al. 2003; Sousa 2006; Senka 
Dzidic 2008; Jayaraman 2009). 
 
ii. Inhibition of nucleic acids synthesis due to ligation of the antibiotics to DNA 
topoisomerase type II (gyrase) or topoisomerase type IV enzymes, inhibiting 
the replication and the transcription (Tenover 2006; Murray 2009). 
 
iii. Inhibition of protein synthesis and translation due to irreversible ligation of the 
antibiotics to ribosomal subunits (Mc Dermott, Walker et al. 2003; Senka 
Dzidic 2008; Murray 2009).  
 
iv. Inhibition of folic acid synthesis and nucleotides biosynthesis by ligation of the 
antibiotics to dihydropteroate synthase (DHPS) and dihydrofolate reductase 
(DHFR) (Mc Dermott, Walker et al. 2003; Tenover 2006; Senka Dzidic 2008).
 Table 1 - Modes of action of the main classes of antibiotics that are effective against most Gram-negative bacteria species (adapted by Murray 2009). 
Classes of antibiotics Activity spectrum Action Mode of action Chemical structure 
β-lactams Broad/Narrow Bactericidal Bind PBPs and enzymes responsible for 
peptidoglycan synthesis 
 
β-lactam / β-lactamase 
inhibitor 
  Bind β-lactamases and prevents 
enzymatic inactivation of β-lactam 
Aminoglycosides Broad Bactericidal Produce premature release of aberrant 
peptide chains from 30S ribosome 
 
Macrolides, Ketolides, 
Clindamycin, 
Streptogramins 
Broad Bacteriostatic Prevent polypeptide elongation at 50S 
ribosome 
 
Chloramphenicol Broad Bacteriostatic Binds to the 50S ribosomal subunit 
blocking peptidyltransferase reaction  
Quinolones Broad Bactericidal Bind α-subunit of DNA gyrase 
 
Rifampicin Broad Bactericidal Prevent transcription by binding DNA-
dependent RNA polymerase 
 
Sulfonamides and 
Trimethoprim 
Broad Bacteriostatic Inhibit DHFR and DHPS enzymes, leading 
to disruption of the folic acid synthesis  
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2. DEVELOPMENT OF ANTIBIOTIC RESISTANCE  
 
All classes of antibiotics are efficacious against different bacterial species, since they 
inhibit specific physiological and metabolic essential functions (Smith and Romesberg 
2007). However, this potential has been lost due to the ability of bacteria to develop 
strategies that permit to acquire adaptive characteristics to survive in the presence of 
these compounds. Several studies show that the exposure to drugs is the factor that has 
most contributed to emergence of resistance in microorganisms, such as in fungi and 
bacteria (Levy and Marshall 2004).  
 
Thus, antibiotic resistance can be defined as a result of classical Darwinian hypothesis, 
"survival of the fittest", since the selective pressure exerted by inappropriate and 
indiscriminate use of the antibiotics, allows the adaptation of the microorganisms more 
resistant (Figure 2) (Smith and Romesberg 2007). Indeed, the whole period of antibiotic 
use can be considered as one large ongoing experiment designed to test this hypothesis, 
and nowadays, a set of arguments, suggest that the hypothesis of Darwin was surprisingly 
confirmed (Bennett 2008). 
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Figure 2 - In the presence of antibiotic selective pressure, some bacteria make no improvement 
and are lost from the population over time – susceptible bacteria. However, those that confer an 
adaptive advantage are conserved and multiply, becoming more common and developing an 
infection – resistant bacteria (Jacoby 2009). 
 
 
The ability of microorganisms to acquire resistance to antibiotics has surpassed our 
imagination. Currently, the bacterial evolution culminate in emergence of resistance to a 
range of antibiotic compounds (Harbottle, Thakur et al. 2006), designated by multidrug-
resistance (MDR) bacteria (Smith and Romesberg 2007), which is characterized by the 
ability of microorganisms to be resistant to more than three classes of these compounds 
(Tenover, et al. 2006; Mulvey and Simor 2009). Moreover, it seems that there is a directly 
proportional relationship between the introduction of a new class of antibiotics in the 
therapeutics and the arising of bacterial resistance (Figure 3), a phenomenon referred as 
co-evolution (Mulvey and Simor 2009). 
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Figure 3 - Emergence of drug-resistant bacteria in response to development of antibiotics 
(Yamaguchi 2009). 
 
 
The resistant microorganisms have mainly a clinical origin, since it is in hospitals that 
antibiotics are used in large scale (Mc Dermott, Walker et al. 2003; Sousa 2006). In fact, in 
a short period of time, clinical strains resistance has been observed for almost all classes 
of antibiotics available (Mc Dermott, Walker et al. 2003). Moreover, MDR strains are not 
only confined to the hospital setting and can be widely spread in the environment 
(Tenover 2006; Mulvey and Simor 2009), since some antibiotics are stable chemical 
compounds and remain active in the natural environments for a few years (Alekshun and 
Levy 2007). 
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The outcome of the excessive use of different classes of antibiotics in diverse areas, as 
agriculture, livestock and veterinary medicine, have also contributed to the emergence of 
resistance bacteria (Stefan and Elisabeth 2001; Harbottle, Thakur et al. 2006; Summers 
2006; Sipahi 2008), and their entry in the food chain allow the dissemination in 
environment (Figure 4) (Shea 2003; Senka Dzidic 2008). 
 
 
                    
 
 
 
 
 
         
 
                         
Figure 4 - The food chain can be a vehicle to the dissemination of bacteria that cause infections. 
The excessive and misuse of antibiotics in different areas leads to the emergence of MDR bacteria 
(http://images.google.com/). 
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In resume, the rapid development and use of different classes of antibiotics and the 
success of adaptive bacteria contributed to the MDR, which currently is one of the largest 
and more worrying clinical problems worldwide, threatening the well-being of Man, 
which needs to be well understood in order to be overcome (JM Conly 2005; Mulvey and 
Simor 2009). So, the use of antibiotics is not a free act, but an act of intelligence (Sousa 
2006). 
 
 
 
2.1 Antibiotic resistance mechanisms 
 
Bacteria are better genetic engineers than Man and will continue the escape of the 
antibiotics effects, since they have the ability to develop different adaptive solutions 
(Barlow, Pemberton et al. 2004). 
 
In order to survive to antibacterial chemotherapy, most Gram-negative bacteria have 
developed five main antibiotic resistance mechanisms, as shown in Table 3: 
 
i. Inactivation and/or degradation of the antibiotics by specific enzymes; 
ii. Reduce antibiotic accumulation by efflux pumps; 
iii. Alteration or loss of target site by mutations; 
iv. Changes in the cell permeability due to porins; 
v. By-pass of metabolic pathway. 
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Table 2 - Mechanisms of resistance developed by a majority of Gram-negative bacteria, in 
response to different classes of antibiotics (Senka Dzidic 2008; Jayaraman 2009; Mulvey and Simor 
2009). 
Resistance mechanism Antibiotic affected by 
bacterial resistance 
Resistant bacteria 
Antibiotic inactivation 
 
β-lactamases enzymes 
(ESBLs and MBLs) 
Penicillins, 
cephalosporins, 
cefotaximes, 
carbapenems 
Escherichia coli, Klebsiella spp., 
Proteus spp., Enterobacter spp., 
Serratia spp., Pseudomonas 
aeruginosa 
Aminoglycoside inactivating 
Enzymes (aac / aad genes) 
Gentamicin, tobramycin, 
amikacin, streptomycin 
 
 
 
Enterobacteriaceae 
 
Chloramphenicol 
acetyltransferase (cat gene) 
Cloramphenicol 
Dihydrofolate reductase 
(dfr gene) 
Trimethoprim 
Dihydropteroate synthase 
(sul gene) 
Sulfonamides 
Altered target site 
Altered PBPs Penicillins Enterobacteriaceae 
Mutations in the DNA 
gyrase or topoisomerase 
Ciprofloxacin, 
norfloxacin, levofloxacin 
Enterobacteriaceae,  
P. aeruginosa 
Decreased access to the target site 
Change in outer 
membrane proteins or 
porins (OprD and OMP) 
Tobramycin, gentamicin Enterobacteriaceae 
P. aeruginosa 
Efflux pump (AcrAB and 
MEX systems) 
Erythromycin, 
tetracycline, ciprofloxacin 
E. coli, P. aeruginosa 
Target by-pass 
By-pass of metabolic 
pathway 
Sulfonamides and 
Trimethoprim 
E. coli 
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These mechanisms may be present in various bacterial species or only in some strains 
of a species (Harbottle, Thakur et al. 2006), and frequently there is more than one type of 
resistance mechanism to one antibiotic (Levy and Marshall 2004) (Figure 5). 
 
 
Figure 5 – Sites of action of the main classes of antibiotics and potential bacterial mechanisms of 
resistance to antibiotics (Mulvey and Simor 2009). 
 
 
 
2.2 Acquisition and dissemination of resistance genes 
 
Several published studies showed that bacterial resistance is caused by the 
articulation of intrinsic or acquired genetic resistance mechanisms (Barlow, Pemberton et 
al. 2004). 
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2.2.1 Intrinsic resistance 
 
Intrinsic resistance occurs naturally in the bacterial cell, which does not suffer any 
genetic or biochemical change in the genome, and therefore developed their own 
mechanisms of resistance without addition of new genetic information (Harbottle, Thakur 
et al. 2006; Senka Dzidic 2008). The production of enzymes, such β-lactamases that 
inactivate the antibiotic is the main intrinsic mechanism of resistance, and arises in many 
species of Gram-negative bacteria (Mulvey and Simor 2009). Intrinsic resistance is also 
associated with efflux pumps, present in P. aeruginosa isolates, which show a low degree 
of susceptibility to hydrophobic antibiotics such as macrolides, because they had 
difficulties in crossing the outer cell membrane, and both are driven by the activity of 
efflux pumps (B. Henriques Normark 2002; Mc Dermott, et al. 2003). 
 
 
2.2.2 Acquired resistance 
 
Acquired resistance consist in the capture and insertion of new genetic elements, as 
well as in the occurrence of “adaptive mutations” (deletions, insertions or inversions of 
bases) in structural or regulatory genes. These processes happen randomly and change of 
the genetic makeup of the microorganism (Bennett 2008), since they can change the 
capacity of bacteria to survive the antibiotics action, by preventing their access or binding 
to the target (B. Henriques Normark 2002; Alekshun and Levy 2007; Senka Dzidic 2008; 
Mulvey and Simor 2009). 
 
Resistance determinants can be inherited by vertical gene transfer (VGT), when they 
pass through generations as the cells divide, or they can be acquired by horizontal gene 
transfer (HGT). The latter assumes the movement of genetic material between bacteria 
other than by descent (Harbottle, Thakur et al. 2006; Mulvey and Simor 2009). The HGT is 
associated with mobile genetic elements (MGEs), and occurs through three different 
processes (Figure 6). 
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i. Transformation 
 
The transformation was the first mechanism of HGT to be discovered among 
prokaryotes (Harbottle, Thakur et al. 2006). This process involves the transfer of cellular 
DNA between closely related bacteria and is mediated by chromosomally encoded 
proteins that are found in some naturally transformable bacteria (Frost, Leplae et al. 
2005). Initially there is release of DNA from a donor dead or lysed cell (Alekshun and Levy 
2007), or in some bacteria, at a specific point in the growth cycle. This DNA is degraded 
and broken into fragments that are uptaken and incorporated into the competent 
recipient chromosome (Clewell 2005; Tenover 2006). Transformation is thus limited to 
moving variants (alleles) of shared chromosomal genes around among strains of a 
bacterial species. Heterologous genes would not be able to recombine and would be 
degraded by the recipient’s nucleases (Summers 2006). 
 
 
ii. Conjugation  
 
The conjugation is mediated by self-replicating double stranded DNA molecules, 
typically circular called conjugative plasmids or chromosomally integrated conjugative, 
which included conjugative transposons (Alekshun and Levy 2007). This process involves 
the mobilization of resistance genes, through cell-to-cell contact by a long protein 
structure, designated sex pilli or fimbriae, which facilitate the transfer of cellular DNA 
from the donor plasmid-carrying cell to a recipient cell that lacks the plasmid or 
integrated conjugative elements (Frost, Leplae et al. 2005; Summers 2006). During this 
mechanism, occurs the transfer of only a single strand of the plasmid from the donor cell 
to receptor cell, and a second strand is synthesized. So, the conjugation is a replicative 
process, since both bacteria keep a copy of the plasmid transferred with the resistance 
genes, but additional copies can be produced (Tenover 2006). 
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iii. Transdution  
 
The transduction is mediated by independently replicating bacterial viruses called 
bacteriophages or phages that use the transposition to replicate (Frost, Leplae et al. 2005; 
Tenover 2006; Bennett 2008). At low frequency, bacteriophages can accidentally package 
segments of host DNA in their capsule and can inject this DNA into a new host, in which it 
can recombine with the cellular chromosome and be inherited (Frost, Leplae et al. 2005). 
Some of these fragments of the host DNA will contain resistance determinants (Mc 
Dermott, Walker et al. 2003). Genetic exchange via transduction involves bacteriophage 
infection of a bacterium, phage replication, and packaging of some of the bacterial DNA 
with the phage DNA (which may include resistance determinants), lyses of that 
bacterium, and infection of subsequent bacteria. Upon subsequent infection, those 
resistance determinants may be transferred to the infected bacterium (Harbottle, Thakur 
et al. 2006). 
 
 
                                          
 
Figure 6 – Schematic representation of the processes that contribute to acquisition of resistance 
genes: conjugation, transformation and transduction (http://images.google.com). 
 
Transformation  Conjugation  Transduction  
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All these processes of the acquisition and dissemination of resistance genes allow that 
any opportunistic or susceptible bacteria could become MDR and potentially pathogenic 
when presenting virulence factors (Clewell 2005; Tenover 2006; Alekshun and Levy 2007; 
Bennett 2008). Moreover, these mechanisms contribute to the rapid dissemination of 
resistance determinants among several bacterial genera (Harbottle, Thakur et al. 2006), 
through MGEs (Bennett 2008; Tetu and Holmes 2008; Mulvey and Simor 2009).  
 
 
3. MOBILE GENETIC ELEMENTS ASSOCIATED WITH ANTIBIOTIC RESISTANCE 
 
As referred above, the bacterial respond to antibiotics, antiseptics, disinfectants and 
heavy metals used in clinical medicine depends of factors such as mutations in 
physiological genes and selective pressure, but also of movement of different resistance 
genes by HGT and VGT. These are the predominant factors for the escalation of antibiotic 
resistance in more than half a century (Toleman, Bennett et al. 2006).  
 
The majority of resistance genes are associated to MGEs such as plasmids, 
transposons, insertion sequences (IS), integrons and bacteriophages (Bennett 2008; Tetu 
and Holmes 2008; Mulvey and Simor 2009). These structures catalyze the DNA movement 
and play an important role in the dissemination of antibacterial resistance genes. 
Therefore, they contribute to bacterial genetics evolution, since they allow the rapid 
bacterial adaptation to new classes of antibiotics in the environment (Tenover 2006), 
increasing the rate of MDR and potential pathogenic strains (Tetu and Holmes 2008). 
Consequently, it is of extreme importance the understanding of MGEs genomics, in order 
to take advantage and avoid the dangers of these ‘natural genetic engineers’ (Frost, 
Leplae et al. 2005).  
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3.1 Plasmids  
 
The plasmids are described as DNA extra-chromosomal molecules, since replication 
happens independently of replication of the bacterial chromosome (Mc Dermott, Walker 
et al. 2003; Summers 2006), and can be distinguished by their origins of replication 
(Alekshun and Levy 2007; Bennett 2008). These structures are not essential for the 
survival of the bacterial cell (Mc Dermott, Walker et al. 2003), but when present carry 
genes that confer a selective and adaptive advantage for bacterial cell, namely resistance 
to antibiotics (Harbottle, Thakur et al. 2006; Mulvey and Simor 2009). 
The classical plasmids are circular double-stranded DNA molecules, smaller than the 
cellular chromosome (the size is variable and depend of the plasmid type), and usually 
does not accommodate any of the set of core genes needed by the cell for basic growth 
and multiplication (Clewell 2005; Frost, Leplae et al. 2005; Summers 2006; Bennett 2008). 
The plasmids may serve as vehicles for transposons and integron (Mc Dermott, 
Walker et al. 2003; Summers 2006; Bennett 2008), which are transferred within the same 
specie or between different bacterial species (B. Henriques Normark 2002; Alekshun and 
Levy 2007). This movement is random and independent of the use of antibiotics. However 
these compounds supply a powerful selective pressure that contribute to the MDR, which 
have increased in both pathogens and opportunists Gram-positive and Gram-negative 
bacteria (Levy and Marshall 2004; Harbottle, Thakur et al. 2006). 
 
Resistance to almost all classes of clinically important antibiotics can be mediated by R 
plasmids (initially R factors) (Bennett 2008), which were first discovered in penicillin-
resistant bacteria in the 1950s. Given their nature, R-plasmids are mobile and carry one or 
more resistance genes (Li 2005), such as for toxic heavy metals, certain antiseptic 
compounds and disinfectants among different Gram-negative (Bennett 2008) (Figure 7). 
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Figure 7 – Schematic representation of a resistance plasmid, with three main regions: origin of 
replication, antibiotic resistance genes and promoter associated to a coding sequence 
(http://images.google.com).  
 
 
Conjugative plasmids can exhibit broad or narrow host range. Some broad host range 
plasmids from Gram-negative bacteria appear to have no host limitation within the 
division and, ‘in vitro’ experiments have shown that they are able to transfer, but not 
survive in Gram-positive bacteria. One example of a broad host range plasmid is the 
resistance plasmid RP1 (also known as RP4 and RK4), first identified in a clinical strain of 
P. aeruginosa that is able to transfer productively to most, if not all, Gram-negative 
bacteria (Bennett 2008). 
 
Plasmids must replicate, control their copy number, and ensure their inheritance at 
each cell-division. Plasmids of different modes of replication are able to reside in the 
same bacterium, while two different plasmids with the same replication mechanism are 
mutually incompatible and are unable to coexist in the same bacterium for prolonged 
periods (Harbottle, Thakur et al. 2006). This phenomenon is termed by ‘incompatibility’ 
(Inc) (Frost, Leplae et al. 2005). They are categorized into Inc groups according to their 
mode of replication and maintenance in a bacteria cell (Clewell 2005). Examples of Inc 
groups have been defined for plasmids of the Enterobacteriaceae, Pseudomonas spp. and 
some Gram-positive isolates (Frost, Leplae et al. 2005). 
21 
 
Other plasmid types lack the genes that encode the functions that allow the transfer 
of DNA, but may still be mobilized by conjugative elements by the formation of transient 
or stable fusions, called co-integrates, that occur as part of a homologous or specifically 
directed recombination process (Bennett 2008).  
 
 
3.2 Transposons 
 
Transposons belong to the set of transposable elements and they are characterized as 
MGEs of DNA, since they mediate the movement of the DNA due to their ability to “jump” 
and to recombine randomly between replicons (Harbottle, Thakur et al. 2006), and 
therefore they are important motors of genetic variability (Frost, Leplae et al. 2005). They 
can “jump” from one site to another within a DNA molecule – intracellular movement, or 
from one DNA molecule to another – intercellular movement (Mc Dermott, Walker et al. 
2003; Harbottle, Thakur et al. 2006). Due to their location in phages or more typically in 
plasmids, these structures carry resistance genes to different classes of antibiotics, 
allowing their dissemination (Summers 2006; Senka Dzidic 2008). 
 
In general, these MGEs are made up of insertion sequences (IS) of DNA and encode a 
site-specific enzyme responsible for the transposition, called transposase, that participate 
in recombination and facilitates the incorporation into specific genomic regions 
(Harbottle, Thakur et al. 2006; Alekshun and Levy 2007). The IS are usually flanked by 
inverted repeated sequences corresponding roughly to 25 to 50 nucleotides, which are 
recognized by the transposase (Summers 2006) (Figure 8). Target sites for IS often have 
little specificity and therefore insertion and recombination can occur almost anywhere in 
genome, where genetic mutations are commonly generated (Bennett 2008). 
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Figure 8 – General structure of a transposon (http://images.google.com). 
 
 
Bacteria contain a large number of transposable elements that can be categorized in 
groups according to their mechanisms of transposition (B. Henriques Normark 2002; 
Clewell 2005; Summers 2006). Thus, the transposons can be mainly grouped in IS 
elements, complex and conjugative transposons (Harbottle, Thakur et al. 2006; Alekshun 
and Levy 2007; Bennett 2008; Tetu and Holmes 2008).  
 
 
3.3 Integrons 
 
Integrons were discovered in 1989, and initially were defined as DNA elements, 
potentially mobile and located in independents sites (H. W. Stokes 1989). But nowadays, 
these genetic systems are defined as DNA elements that cannot move by themselves, but 
have the ability to capture genes, that confer antibiotic resistance, being designated as 
natural reservoirs (Bennett 2008; Senka Dzidic 2008; Mulvey and Simor 2009).  
 
The feature that defines these integrons is a site-specific recombination system 
(instead of transposition), capable of integrate and express open reading frames (ORFs) 
and convert them to functional genes (Rowe-Magnus and Mazel 1999). These ORFs are 
contained in modular structures called mobile genes cassette and have contributed 
greatly to the mobilization, rearrangement and dissemination of antibiotic resistance 
among bacteria (Harbottle, Thakur et al. 2006; Labbate, Case et al. 2009). 
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These gene capture systems act as natural expression vectors for any gene cassette, 
and are located on the bacterial chromosome or on plasmids, frequently associated to 
transposons. So, as they are intimately associated to antibiotic resistance genes and to 
MGEs, the dissemination of these “genetic tool box” is facilitated (Summers 2006; Senka 
Dzidic 2008). For this reason, they also contribute greatly to the problem of the 
emergence of MDR bacteria and nosocomial infections, due to HGT that have become 
generally widespread as a result of human activities (Labbate, Chowdhury et al. 2008; 
Sally, Guy et al. 2009).  
 
Although it was once believed that integrons were mainly limited to Gram-negative 
bacteria, recently they have been found in many other closely and distantly related 
bacteria such as Salmonella, Enterococci and Staphylococci, not only associated with the 
hospital environment but also with the food (Summers 2006). In fact, their diversity is 
greater in environmental isolates than in clinical isolates, suggesting that integrons are 
ancestor structures in genomes of bacteria from the environment (Labbate, Case et al. 
2009). 
 
 
3.3.1 Integron’s structure  
 
As referred previously, integrons have a specific and distinctive structure, making 
them unique (Figure 9). These DNA elements are usually characterized by three regions: 
two conserved segments (CS) flanking a central region, designated as variable region (VR), 
in which “genes cassette” can be inserted (Mc Dermott, Walker et al. 2003; Harbottle, 
Thakur et al. 2006). The VR, as the name indicates, presents a sequence and a length 
variable. This variability is due to the constitution of this region, depending of the number 
and identities of antibiotic resistance genes (Bennett 2008). The VR constitution is only 
possible due to the presence of a specialized recombination system consisting of a gene, 
intI, which encodes a site-specific recombination enzyme called an integrase. This gene is 
located in the integron’s 5’-CS (Bennett 2008). 
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Each part of the integron’s genetic structure will be discussed in the following 
sections. 
 
 
Figure 9 – Schematic representation of the general integron’s structure.  
 
 
 
 
3.3.1.1 5’-Conserved regions (5’-CS) 
 
The 5’-CS consists of a site-specific integrase enzyme (intI gene) oriented opposite to 
the direction of its associated cassettes, followed by the attachment site attI, in which 
DNA sequences are inserted. The presence of a promoter (Pc) has not been functionally 
demonstrated for all integron classes (Labbate, Case et al. 2009), but when present 
permits the expression and transcription of the genes cassette integrated in the VR 
(Summers 2006). 
 
IntI belongs to super-family of site-specific recombinases, known as tyrosine 
recombinases or integrases (Clewell 2005; Senka Dzidic 2008). This super-family presents 
a number of short regions of similar and conserved residues that are part of the catalytic 
site, and these features are all located in a large C-terminal domain of a 180 amino acids. 
These conserved residues are not found in other tyrosine recombinases, and therefore 
these enzymes can be identified on basis of this motif. Any deletion or substitution in this 
region can abolishes the integrase activity (Christina M. Collis 2002). Thus, IntI enzyme 
facilitates the capture, integration and excision of gene cassettes in VR. 
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Recombination site attI site is located adjacent to the intI gene in the integron. The 
attI site presents a simpler structure and conserved than attC (Karin, Ola et al. 1997; Sally, 
Guy et al. 2009). The general structure is GTTRRRY/RYYYAAC (R = Purina and Y = pirimide) 
(Recchia, Stokes et al. 1994).  
 
The promoter Pc (formerly Pant) does not make part of the site-specific recombination 
system, but it permits the expression and transcription of the genes cassette inserted in 
the VR, and is located within the coding sequence of intI1 (Labbate, Case et al. 2009). In 
some integrons, a second promoter (P2) complement the Pc and is located 119 bp 
downstream from Pc, and is formed by an insertion of three G bases optimizing the 
spacing (17 bp) between the -35 and -10 sites (P2 active) (Costas C. Papagiannitsis 2009; 
Sally, Guy et al. 2009). Several Pc variants have been identified (“weak”, “strong”, “hybrid 
1” and “hybrid 2”) due to differences in the -35 and/or -10 sequences, and different 
combinations have been characterized in some integrons (Costas C. Papagiannitsis 2009). 
 
The integration process has been shown experimentally for the class 1 and class 3 
integrons, where the cassettes insertion reaction preferentially occurs by IntI-catalysed 
homologous recombination between two architecturally distinct sites, attI and attC sites 
(Figure 10). Insertion occurs from the 5’ end to the 3’end, and cassettes initially in a free 
and inactive circular form, when inserted in VR acquire a linear and active form. In the 
case of excision of cassettes, this process occurs also via homologous recombination 
between attI and attC sites or between two attC sites, and cassettes again acquired a 
circular form (Bennett 2008; Labbate, Case et al. 2009). 
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Figure 10 – Schematic representation of the recombination and integration of the genes cassette 
in the VR, catalyzed by integrase enzyme. 
 
 
Recognition and integration processes of cassettes are mediated by IntI enzyme that 
use a tyrosine residue as the nucleophile to catalyze strand exchange reactions in an 
ordered fashion and recombine with the core sites of the attC (Christina M. Collis 2002). 
Both the core sites of the attC are directly oriented to IntI binding sites and are essential 
for efficient activity of attI when an attC site is present (Sally, Guy et al. 2009). The 
current model for IntI1-catalysed site-specific recombination, described by Mazel and 
their colleagues (Mazel 2006), involves the bottom strand of the attC site only folded into 
a bulged hairpin structure. The folded attC recombines with a double-stranded attI or 
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another attC site and a subsequent replication step is required to resolve the Holliday 
junction intermediate (Figure 11). The analysis of transcripts originating from Pc suggests 
that the stem-loop structures formed by attC sites might be acting as transcription 
terminators (Sally, Guy et al. 2009). 
 
 
 
Figure 11 – Model of the recombination molecular mechanism using an attC and an attI site 
(Bouvier, Demarre et al. 2005). 
 
 
Genes cassette can be deleted and newly inserted in another order, and therefore a 
promoter-distal cassette can become a promoter-proximal cassette and a new resistance 
phenotype can appear (Summers 2006). 
The expression and transcription of genes cassette inserted in the VR may terminate 
before all cassettes transcribed. This processes depend not only on the strength of 
promoter but is also influenced by the position of the cassettes in the array in relation to 
promoter (Toleman, Bennett et al. 2006), and by the sequence of the respective attC 
(Rowe-Magnus and Mazel 2002; Labbate, Case et al. 2009). These factors explain 
different bacterial resistance phenotypes (Costas C. Papagiannitsis 2009). 
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3.3.1.2 Variable region (VR) 
 
The discrete units that compose the VR are known as mobile genes cassette and are 
located downstream of the resident promoter (Rowe-Magnus and Mazel 1999). The high 
level of unknown proteins encoded by the genes cassette and their origin has made it 
difficult to understand the adaptive roles of the cassettes in bacterial evolution. 
Nevertheless, some cassettes have been shown to include ORFs encoding specific 
advantageous functions (Labbate, Case et al. 2009).  
Genes cassette are defined as the smallest mobile genetic entities that are 
independently mobilizable and can carry resistance determinants, but are not expressed 
on their own due to the lack of the promoter region (Senka Dzidic 2008). They are 
composed by a single gene and an IntI-recognizable recombination site called 59-base 
element (59-be) or attC site located downstream of the region of the gene cassette 
(Toleman, Bennett et al. 2006; Sally, Guy et al. 2009). 
 
The analysis of the gene sequences allows grouping the cassettes according to their 
role and identity. Nowadays there are approximately 132 different cassettes carrying 
known antibiotic resistance genes (or homologous assumed to confer similar resistance 
phenotypes) and 62 different ORFs of unknown function, recently designated by gcu 
(Sally, Guy et al. 2009). The nomenclature of the new cassettes is not formally regulated, 
and several authors gave the same name to two different cassettes, or to the same gene 
different names have been given, using the roman and arabic numerals, as for example 
dhfrVII and dfr7, for a dihydrofolate reductase (Sally, Guy et al. 2009). Other problems in 
the nomenclature of the cassettes are the emergence of the ‘hybrids’ formed by 
homologous recombination between two closely related cassettes (89% identical) (Sally, 
Guy et al. 2009), or the fusion of cassettes due to deletions in the ends of two adjacent 
cassettes (Recchia and Hall 1995). These changes can be associated with the reduction of 
the resistance level (Levings, Lightfoot et al. 2006). Examples of hybrid cassettes appear in 
blavim-12 gene (Pournaras, Ikonomidis et al. 2005), which was automatically annotated as a 
partial blavim-1 followed by a partial blavim-2 cassettes (Sally, Guy et al. 2009), and aadA1 
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and aadA2 hybrid genes and several variants of these cassettes are known (Partridge, 
Collis et al. 2002; Gestal, Stokes et al. 2005). 
Several minor variants have been identified in some cassettes, and may have 
implications in the movement and expression of cassettes, dramatically changing the 
resistance phenotype. These resistance genes can be useful as epidemiological markers 
(Sally, Guy et al. 2009).  
Formerly, the recombination site of genes cassette was designed by 59-be, due to the 
length of sequence, but in fact, very few elements have this size, although the term 
continues to be found in the literature. In recent years, the term attC has been 
introduced and became favored, because it is more consistent with the terminology used 
to describe site-specific recombination sites in general (Labbate, Case et al. 2009).  
attC sites are highly conserved in some species, but varies in length and sequence 
depending of the gene cassette (from 55 to 141 bp), and closely related cassettes may be 
associated with similar or different attC sites, suggesting divergence from a common 
ancestral cassette or different origins, respectively (Poirel, Naas et al. 2000; He Yan 2007; 
Sally, Guy et al. 2009). These sites are composed by simple sites (also called core sites) 
that have approximately 20 bp and are associated to regions, called imperfect inverted 
repeat sequences (Clewell 2005; Labbate, Case et al. 2009). These regions referred as 
L’/L’’ and R’’/R’ are separated by a spacer of 6–8 bp (also called central region) that varies 
in length and sequence between attC sites. Analysis of some attC site sequences in 1997 
(H. W. Stokes 1997) suggested the consensus sequence GTTAGSC/GYTCTAAC for R’/L’, 
where GTT nucleotides (completely conserved residues of the R’) are the crossover point 
with IntI. The recombination happens between the G and first T of R’ (Recchia, Stokes et 
al. 1994) (Figure 12). L’’/R’’ are quite variable and difficult to identify conclusively for 
some attC sites (Sally, Guy et al. 2009). 
All these sites are important for attC sites activity, but sometimes deletions or 
changes occur that interfere with the integration and expression of the genes cassette.  
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Figure 12 – Integron recombination sites. a. The sequence of the double-stranded attC site. b. The 
proposed secondary structure for the attC bottom strand. The asterisk shows the position of the 
protruding G base present in L’’ relative to L’. The putative IntI1-binding domains are marked with 
boxes (Mazel 2006).  
 
 
3.3.1.3 3’ Conserved region (3’-CS) 
 
The 3’-CS, consists of a truncated copy of qacE gene, which when intact confers 
resistance to quaternary ammonium compounds, followed by a sul1 gene that confers 
resistance to sulfonamides (He Yan 2007; Labbate, Case et al. 2009). Initially, downstream 
of sul1, an orf513 gene of unknown function was present (Bennett 2008), but nowadays, 
this gene is referred as ISCR1 (Toleman, Bennett et al. 2006; Labbate, Chowdhury et al. 
2008). 
The majority of the cassettes arrays are flanked by 5’-CS and 3’-CS (approximately 
300 different cassette arrays are described in the GenBank), and are composed of a few 
genes cassette. This type of arrays is present mainly in E. coli, P. aeruginosa, A. baumanii 
and K. pneumoniae, and recently has also been reported in some Gram-positive bacteria 
(Sally, Guy et al. 2009).  
In other cases, the 3’-CS is absent, and the cassette arrays can be flanked by a 5’-CS 
and a complete tni region downstream of the inserted cassettes that is present in Tn402 
(also called Tn5090), found in plasmid R751 and pTB11 (Labbate, Case et al. 2009; Sally, 
Guy et al. 2009). The outer boundary of the 5’-CS is defined by a 25-bp inverted repeat 
b. 
a. 
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sequence called IRi and IRt, and when present is found beyond the 3’-CS. The IRi/IRt 
inverted repeats are a feature of transposon and define their limits, and are required for 
transposition using a suite of four transposition genes designed by tni module (tniR, -Q, -
B, -A) (figure 13) (Labbate, Case et al. 2009).  
 
 
 
 
Figure 13 – Evolution of the class 1 integrons. The origin of class 1 integrons is believed to have 
come from a chromosomal location. A class 1 integrons eventually became associated with tni 
functions represented by the Tn402 structure. Partial deletion of the qacE cassette and insertion 
of sul1 resulted in formation of the 3’-CS commonly found in clinical class 1 integrons (Labbate, 
Case et al. 2009).   
 
 
Recent publications suggest that the Tn402-like transposon is the ancestral mobile 
form of the clinical class 1 integron, and that deletions, insertions, and recombination 
events resulted in the genesis of the 3’-CS and the partial loss of tni functions. This is 
supported by the presence of a qacE gene cassette in Tn402 that is 100% identical to the 
equivalent region present in the truncated qacE gene of the 3’-CS, suggesting a partial 
deletion event had occurred possibly as a result of the sul1 insertion (Labbate, Case et al. 
2009). Class 1 integrons with tni in place of the 3’-CS are less frequent, but structures with 
the 3’-CS are likely to be at a selective advantage due to the presence of sul1 gene (Sally, 
Guy et al. 2009).  
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Another type of structure has emerged, where cassette arrays are flanked by the 
usual 5’-CS, but lack the 3’-CS and/or tni region. Recently, a region containing the sul3 
sulfonamide resistance gene has been found in E. coli and Salmonella sequences 
deposited in the GenBank (Sally, Guy et al. 2009). Moreover, the analysis of other 
sequences that contain a cassette array but lack the 3’-CS revealed several other possible 
explanations involving various IS associated with resistance plasmids, such as IS6100 and 
IS1353 (Partridge, Brown et al. 2001).  
 
 
3.3.2 Integrons classification 
  
Comparative analysis of the amino acid sequences of integrase enzymes have been 
used as a basis for dividing integrons into “classes”, with those carrying intI1 defined as 
“class 1”, intI2 as “class 2”, intI3 as “class 3” and so on (Mazel 2006; Sally, Guy et al. 
2009). However, other studies made at level of insertion and excision reactions, showed 
that attI and attC sites differ between classes, but yet there is no reason to assume that 
the two reactions are equivalent in relation to recombination efficiency (Labbate, Case et 
al. 2009). 
 
To date, different cassette arrays of integrons are divided into nine classes (He Yan 
2007), which can be divided in two main types: resistance integrons (RI), which are mainly 
present in the clinical environment and can be divided in three classes (class 1, 2 and 3 
integrons), and ‘super-integrons’ (SI), which are present mainly in the community 
associated to class 4 integrons (Tetu and Holmes 2008; Labbate, Case et al. 2009). RIs 
contains few genes cassette (Sally, Guy et al. 2009), while SIs have a complex structure 
typically with long arrays (can incorporate one hundred genes cassette), encoding a 
multiplicity of functions (Mazel, Dychinco et al. 1998; Harbottle, Thakur et al. 2006). 
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Although the phylogenetic origin of these classes of integrons continue unknown, 
there is a close relationship between RIs with SIs from environmental microorganisms 
that has implications in the origin and emergence of the systems in clinical environment. 
An example of this is some attC sites found in cassettes carried by RI that are strongly 
related to those in SIs (Sally, Guy et al. 2009).  
 
In resume, the integrons are ubiquitous and play an important evolutionary role in the 
emergence of MDR between different species (Clewell 2005). 
 
 
3.3.2.1 Resistance integrons 
 
The term RI refer to integrons that carry mainly antibiotic resistance genes conferring 
a resistance phenotype, and that are associated with mobile or potentially mobile 
elements (transposons, plasmids and IS).  
 
RI generally contains few cassettes (usually one to six cassettes) but the associated 
attC sites may be quite varied (Sally, Guy et al. 2009). The degree of homology between RI 
classes (45-58%) suggests that their evolutionary divergence has extended over a longer 
period for more than the 50 years of the antibiotic era (Rowe-Magnus and Mazel 2002). 
In a comparative study with V. cholerae and class 1 integrases, it was possible to verify 
that the intI1 gene recognizes a larger spectrum of attC sites and consequently is able to 
access the gene cassette metagenome. This feature show the mobilization of integrons of 
these classes in Vibrio spp. strains, and an important selective advantage (Labbate, Case 
et al. 2009).  
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i. Class 1 integrons 
 
Class 1 integrons are genetic elements that possess a specific recombination site, 
attI1, into which many combinations of resistance genes can be inserted by site-specific 
recombination (Toleman, Bennett et al. 2006), as previously described in 3.3.1.1 section. 
They are also the most clinically important and broadly distributed integrons in a large 
variety of Gram-negative clinical isolates (22–59 %), but in recent times have been reports 
in some Gram-positive bacteria as Mycobacterium spp. (A. C. Fluit 2004; Harbottle, 
Thakur et al. 2006; Labbate, Case et al. 2009). Thus, this class can be the biggest 
contributor to the global resistance problem. 
 
The ancestor of mobile class 1 integrons may have been generated by acquisition of 
intI1 and attI1 by a transposon of the Tn5053 family to give a structure related to Tn402, 
as previously described in 3.3.1.3 section. Therefore may present a new evolutionary 
advancement in the class 1 integron, and new clinical concerns (Harbottle, Thakur et al. 
2006). This class is usually associated with many different plasmids and transposons, such 
as Tn402-like transposons and Tn3 family (e.g. Tn21 and Tn1696) (Labbate, Case et al. 
2009). The IntI1 enzyme is related with IntI3 enzyme (59%) (Rowe-Magnus and Mazel 
1999; Mazel 2006). 
 
 
ii. Class 2 integrons 
 
The intI2 gene was first described as part of the approximately 14 Kb transposon Tn7, 
which includes the tns transposition region and is bounded by short segments, containing 
transposase-binding sites, called Tn7-L (approximately 150 bp) and Tn-R (approximately 
90 bp), which are necessary for transposition (Labbate, Case et al. 2009).  
Mobility of class 2 integrons is due to usually to association with Tn7, a transposon 
that contains five transposition genes (tnsA, -B, -C, -D, and -E), and preferentially inserts 
at high frequency in a unique specific site within of the bacterial chromosomes, or also 
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able to transpose to other sites, such as conjugative plasmids, but with lower frequency 
(Hansson, Sundstrom et al. 2002; Labbate, Case et al. 2009).   
Examples of the intI2 gene described to date contain an internal stop codon at amino 
acid 179 that renders IntI2 inactive, but natural suppression of this codon or the action of 
other IntI in trans may allow occasional acquisition of new cassettes by capture or 
recombination. This mutation has been attributed to the low diversity of integrated genes 
cassette observed within class 2 integrons (Labbate, Case et al. 2009).  
 
Cassette boundaries in class 2 integrons can be identified, TAATAAAATG is found 
adjacent to the start of the first cassette and TTAGAG defines the start of the ybeA 
cassette usually found at the end of arrays. The most commonly identified array flanked 
by intI2 and ybeA was |dfrA1|sat2|aadA1a|, as seen in Tn7 itself, followed by others 
arrays (Sally, Guy et al. 2009).  
 
This class of integron is low frequent in clinical environment (Labbate, Case et al. 
2009), and has been commonly found in Acinetobacter, E. coli, Shigella and Salmonella (A. 
C. Fluit 2004). 
 
 
3.4 Insertion sequences common regions (ISCRs) 
 
Recently a recombination system that contributes to the assembly of banks of 
resistance genes, mainly on bacterial plasmids, has been described. However, some 
studies show that they also appear associated with the chromosome (Bennett 2008). 
These MGEs were discovered in 1990´s and are linked to sequences termed “common 
regions” (CRs), because the same sequence was commonly found in it. A comparative 
analysis of these CRs has revealed that they are related to each other and resemble a 
family of unusual ISs, designated IS91-like (Toleman, Bennett et al. 2006; Bennett 2008).  
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ISCRs are small cryptic sequences of sizes similar to those of many IS elements, which 
lack the typical terminal inverted repeats of most IS elements, and therefore use the 
common 3’-CS sequence as point of crossover (L. Poirel 2008). Therefore the mobilization 
of any gene from any location is different and designed by rolling-circle (RC) transposition 
(Toleman, Bennett et al. 2006), which permits genetic rearrangements by homologous 
recombination into another class 1 integron (Harbottle, Thakur et al. 2006). Rather they 
possess distinct terminal sequences designated oriIS (origin of replication) and terIS 
(replication terminator) of the RC replication stage, which are relevant to the spread of 
antibiotic resistance genes (Bennett 2008).  
 
The first CR element (now ISCR1) was discovered downstream of the sul1 gene in 3’-
CS of the class 1 integron. Initially these integrons presented the orf513 gene, but 
recently this region gives rise to the ISCR1. Downstream of the ISCR1, there is another VR 
associated to the resistance genes, mainly all classes of β-lactamases, fluoroquinolones, 
trimethoprim, aminoglycosides and chloramphenicol, followed by a duplication of the 3’-
CS (qacEΔ1 and Sul1 genes). This structure is classified as complex class 1 integron 
(Toleman, Bennett et al. 2006; Bennett 2008; Labbate, Chowdhury et al. 2008).  
The particularly striking aspect of these CR-associated resistance genes is the fact that 
are not associated to attC sites, and therefore cannot have been acquired as genes 
cassette, but have the ability to create free circular species that may be transposition 
intermediates (Toleman, Bennett et al. 2006; Toleman, Bennett et al. 2006; Bennett 
2008). 
 
Since the first CR sequence was identified, more than a dozen related elements have 
been discovered worldwide, on plasmids and bacterial chromosomes in both Gram-
negative and Gram-positive bacteria of clinical importance. So, ISCR2 is linked to genes 
encoding resistance to trimethoprim, tetracycline, cloramphenicol and sulfonamides; 
ISCR3 is linked to qac, dfrA10, ereB and yie; ISCR4 to blaSPM-1; and ISCR5 to both blaOXA-
45 and ant4’IIb (Toleman, Bennett et al. 2006; Toleman, Bennett et al. 2006). 
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The most worrying aspect is that ISCR elements are increasingly responsible for 
mobilization and dissemination of resistance genes and are implicated in the construction 
of the MDR strains being a potential clinical problem that, with time, can get worse 
(Bennett 2008). 
 
 
4. MOLECULAR TECHNIQUES EMPLOYED IN THE EPIDEMIOLOGY STUDIES 
 
Currently, almost all Gram-negative bacteria are classified as MDR, because they 
present resistance to more than three antibiotic classes. Over time, the antibiotics most 
frequently used were penicillins, cephalosporins, aminoglycosides and, more recently, 
carbapenems and quinolones (Mulvey and Simor 2009).  
 
Commensal and opportunistic bacteria can contribute to acquisition of nosocomial 
infections. This type of infections is becoming common since they are acquired in the 
hospital environment, and their treatment is compromised due to emergency of MDR 
bacteria. Comparing different studies from around the world, the existence of clonal 
outbreaks of a common “epidemic” strain can be observed, since the resistance genes 
and similar resistance profiles have been observed within the same species in different 
geographic regions (MacGowan and on behalf of the 2008). The spreading of resistance 
determinants is not only due to their mobilization by MGEs, but also by vehicles of 
dissemination, such as hands, surgical materials, surfaces of inanimate hospital 
environment and transfer of patients between hospitals (Levy and Marshall 2004; 
Tenover 2006; Mulvey and Simor 2009).  
 
To reduce the level of nosocomial infections and also resistance, mainly in the 
hospital environment, genetics and functional genomics tools are now being 
implemented in order to give a quicker response and allow a better choice of appropriate 
treatment to the patient (Sipahi 2008). Knowledge in detail of the sites of action of the 
antibiotics and the mechanisms of resistance exhibited by the bacteria cell, the 
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dissemination of resistance genes by HGT and utilization of synergistic of antibiotics is 
necessary (Sousa 2006; Bennett 2008; Senka Dzidic 2008). With this information new 
programs of effective infection control, prevention and epidemiological surveillance can 
be implemented. Consequently, a decrease of the mortality and morbidity rates will be 
observed (Zwar, Wolk et al. 1999; Levy and Marshall 2004; Senka Dzidic 2008; Mulvey and 
Simor 2009). 
 
Studies have been carried out and discussed about the regional and global 
epidemiology and epidemiological relationships between bacteria. To investigate this 
problem, the use of a proper methodology is essential for comparing isolates which are 
temporal and geographically distant and handled by different laboratories. Molecular 
techniques as polymerase chain reaction (PCR),  macrorestriction profiling of genomic 
DNA by pulsed-field gel electrophoresis (PFGE), random amplification of polymorphic 
DNA (RAPD), restriction fragment length polymorphism (RFLP) and multilocus sequence 
typing (MLST) allow to identify the bacteria and to study their resistance profile, 
permitting a bacterial phylogenetic classification (Figure 14), and the characterization and 
location of the integrons structure (Giske, Libisch et al. 2006). Thus, these molecular 
techniques are important in the study of the bacterial infections, since they can be helpful 
on the identification of outbreaks. 
 
 
Figure 14 – Relative resolution of various fingerprinting and DNA techniques (BRUIJN 1997). 
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PCR technique is very sensitive and can detect target sequences that are in extremely 
low copy number in a sample. The exponential amplification from a single copy gene is 
quick and possible through the use of a temperature-resistant DNA Taq polymerase, and 
DNA primers corresponding to known sequences of the gene to be synthesized. The 
annealing temperature and extension period is important to the pairing of the primers 
and amplification of respectively gene.  
PCR is generally useful in DNA diagnostics to check for the presence of a gene or the 
mutational state of a specific gene, to detect hereditary diseases and to study the 
resistance profile of the microorganisms. Moreover, provide information about the 
evolution of the microorganisms and prevalence of resistance genes and mechanisms of 
resistance (Jonas, Spitzmüller et al. 2003). 
 
rep-PCR is a typing technique that permits to amplify highly conserved, repetitive DNA 
sequences, present in multiple copies in the genomes of majority of the Gram-negative 
isolates. Three families of repetitive sequences have been identified, including the 35-40 
bp repetitive extragenic palindromic (REP) sequence, the 124-127 bp enterobacterial 
repetitive intergenic consensus (ERIC) sequence, and the 154 bp BOX element. REP-, ERIC- 
and BOX-PCR genomic fingerprints generated from bacterial isolates permit 
differentiation to the species until strain level, as schematized in Figure 14 (BRUIJN 1997).  
These techniques permit to obtain a distinct banding pattern that help to know and 
study the phylogenetic relationship between different bacterial species. Using computer 
programs it is possible to construct the phylogenetic tree determining different clonal 
groups into the specie (Tenover, Arbeit et al. 1995).  
 
Electrophoresis permits to separate shorter DNA fragments or proteins according to 
molecular size, on gels under the influence of strong electric field. PFGE is more reliable 
and conclusive, and therefore is used to separate the larger DNA molecules, since is 
considered to have both the reproducibility and resolving power of a standard technique 
for the epidemiological typing of bacterial isolates. The DNA fragments are viewed under 
U. V. light, after ethidium bromide (EtBr) staining (Tenover, Arbeit et al. 1995). 
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4.1 Clinic relevant pathogenic bacteria 
  
Treatment of nosocomial infections is worldwide compromised due to emergency of 
MDR bacteria. Thus, molecular and typing techniques are important to study bacteria 
causing infections, since they are very helpful on the identification important outbreaks.  
The more relevant and more problematic Gram-negative MDR bacteria are, for 
example, E. coli, K. pneumoniae, P. aeruginosa and A. baumanii, which will be discussed in 
more detail in the following sections (Alekshun and Levy 2007; Sipahi 2008). 
 
i. E. coli  
 
E. coli is a commensal of the human intestine, but can cause a variety of important 
infections, including those of the gastrointestinal, urinary, biliary, and lower respiratory 
tract septicemia, neonatal meningis, etc. These strains are producers of β-lactamases 
mainly ESBL types (TEM, SHV, OXA and CTX-M), and are therefore highly resistance to β-
lactams antibiotics. Recently, E. coli isolates are becoming resistant to fluoroquinolones 
as result of the mutations in the topoisomerases that increase the expression of 
membrane proteins that extrudes the antibiotic (Levy and Marshall 2004).  
Class 1 integrons are frequent in these strains, and the VR is characterized mainly by 
the presence of genes that confer resistance to aminoglycosides and trimethoprim. Since 
these bacteria are commonly resistant to penicillin and ampicillin, the antibiotics often 
used to treat E. coli infections include the cephalosporins, trimethoprim, ciprofloxacin, 
and aminoglycosides (Martin 2009). 
 
ii. Klebsiella pneumoniae  
 
K. pneumoniae strains are widespread in the environment and in the intestine flora of 
humans and other mammals. Infections are often opportunistic and associated with 
hospitalization, and include pneumonia, urinary tract and wound infections and neonatal 
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meningis. These strains often produce ESBLs enzymes, mainly TEM, CTX-M and more 
recently KPC (Thomson and Bonomo 2005).  
The presence of class 1 integrons that transport cassettes conferring resistance mainly 
to aminoglycosides, trimethoprim and quinolones and more recently, a second VR 
containing ISCR1 has been identified, that contains also resistance genes (Bennett 2008).  
This specie often appears associated with plasmids, and therefore contributes quickly 
to the dissemination of genes cassette.  
Cephalosporins (cefotaxime and ceftriaxone) and aminoglycosides (gentamicin and 
amikacin) are commonly used to treat Klebsiellae infections, however multiple MDR 
strains may limit antibiotic choice (Martin 2009). 
 
iii. Pseudomonas spp.  
 
Pseudomonas spp. is one of the groups with the higher number of MDR bacteria 
species. These bacteria are normal commensal in the human gastrointestinal tract, but 
may colonize other sites when host defenses are compromised, including burns and leg 
ulcers, the respiratory tract of patients with cystic fibrosis or bronchiectasis, urinary tract 
and urethral catheters. P. aeruginosa strains are the most pathogenic, and cause a large 
diversity of infections, because have the ability to grow in the presence of some 
disinfectants (Martin 2009).  
Different studies show that these isolates are resistant to carbapenems due to the 
presence of cassettes of the VIM and IMP types in class 1 integrons, and they are resistant 
to quinolones due to the active transport by efflux pumps (Livermore and Woodford 
2006). A less frequent mechanism is the formation of biofilms, which these strains adopt 
as a sessile lifestyle, and has been frequently observed in lung infections in patients with 
cystic fibrosis (Thomson and Bonomo 2005).  
The colistin, aminoglycosides (gentamicin), broad-spectrum penicillins (piperacillin), 
third-generation cephalosporins (ceftazidime) and quinolones (ciprofloxacin) are the 
antibiotics of choice to treat Pseudomonas spp. infections (Mulvey and Simor 2009).  
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iv. Acinetobacter baumanii  
 
A. baumannii is an important pathogenic and nosocomial bacteria acquired in the 
clinical environment. This bacteria cause infections of different types, such as pneumonia, 
urinary tract infections, wound and bloodstream. Isolates of this genus are usually MDR, 
and the glycylcyclines and carbapenems are the options to treatment (Mulvey and Simor 
2009). It frequently expresses MDR patterns to quinolones, aminoglycosides and β-
lactams (Martin 2009).  
A. baumannii has emerged as an important nosocomial pathogen due to production 
of ESBL, mainly TEM, OXA and ampC (Livermore and Woodford 2006). Most infections are 
caused by limited clones or strains with the propensity to cause outbreaks that often 
involve multiple facilities or countries. This suggests that clones have a greater epidemic 
potential (Lee 2009). 
 
 
5. OBJECTIVES OF THIS THESIS  
 
The continued and imprudent therapeutic use of different classes of antibiotics has 
resulted in the increase of MDR bacteria, due to development or acquisition of antibiotic 
resistance mechanisms.  
Recently, the presence of class 1 integrons has been studied in different Gram-
negative bacteria, and since these structures are associated with MGEs, the dissemination 
of resistance genes in the hospital environment is facilitated. Thus, this is a problem of 
concern and requires a permanent monitoring.  
 
This work has one main objective: 
 
Evaluate the prevalence of determinants of resistance in bacteria collected from 
inanimate surfaces within a hospital environment associated to class 1 integrons. 
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To achieve this main goal the workflow was divided in the following tasks: 
 
1) Isolate Gram-negative bacteria from inanimate surfaces of a female ward 
sanitary facility. 
2) Screen for the presence of class 1 integrons and β-lactamase genes. 
3) Characterize the class 1 integrons found, determine their genetic location to 
evaluate the probably of the dissemination through HGT.  
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1. ABSTRACT 
 
Objective: In the hospital environment, antibiotic resistant strains are not only 
confined to patients but also to the surrounding environment. This is a worldwide 
problem of concern given the selective pressure exerted by overuse of antibiotics in this 
particular environment. With the present study we aimed to assess the prevalence of 
antibiotic resistance genes in bacterial strains collected from inanimate surfaces.  
Methods: Samples were collected with sterile cotton swabs rubbed in the surfaces of 
the toilet, lavatory and door knob of a female ward facility, that were placed in rich 
medium o/n at 37°C. Dilutions were plated in MacConkey agar and incubated as 
previously. Phenotypically different colonies were selected and their clonal relationship 
was determined by rep-PCR. Individual clones were identified using VITEK2 system and 
VITEK2 AES (BioMérieux, Marcy L´Étoile, France). Antimicrobial susceptibilities were 
determined according to guidelines of CLSI standards. Class 1, class 2 integrons and 
presence of β–lactamases gene sequences were screened by PCR, using specific primers. 
Nucleotide and deduced aminoacid sequences were analyzed with Blast and ClustalW 
programs and compared to others in the database.  
Results: Forty-five genetically different strains belonging to genera Escherichia, 
Pseudomonas, Enterobacter, Klebsiella, Citrobacter, Acinetobacter, Serratia, Morganella, 
Proteus, Alcaligenes and Stenotrophomonas, were identified. The intI1 gene was 
amplified in 33 % of the isolates and intI2 gene was not detected. A total of 15 different 
arrays were identified: 47% correspond to novel combinations of genes cassette, never 
described before; 53% were already described in different countries and species, but in 
biological samples from patients or animals. Screening for β-lactamases and metallo-β-
lactamases enzymes revealed the presence of CTX-M (3%), OXA (6%), SHV (16%), TEM 
(66%), VIM (7%) and IMP (2%) variants. The most prevalent β-lactamases were TEM-1 and 
SHV-12 variants, followed by metallo-β-lactamase of the VIM-2 type, which appeared 
always associated with class 1 integron. 
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Conclusions: Class 1 integrons and β-lactamases enzymes are widely spread in the 
hospital environment, particularly among opportunistic strains. These results are 
worrisome, since all the isolates were collected from inanimate surfaces, and possess 
different antibiotic resistance determinants. Moreover, given the selective pressure of 
this environment it seems that these surfaces can act as a reservoir of bacterial antibiotic 
resistant strains that can be acquired by compromised patients, and cause difficult to 
treat infections. 
 
 
Keywords 
Class 1 integrons, β-lactamases enzymes, inanimate hospital surfaces, Gram-negative 
bacteria 
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2. INTRODUCTION 
 
Opportunistic bacteria can cause nosocomial infections due to their ability to survive 
in the presence of antibiotics. The selective pressure caused by use and overuse of 
antibiotics, can help the bacteria to develop resistance mechanisms, such as inactivation 
and efflux of the antibiotics, mutations in the ribosomal subunits and altered membrane 
permeability (Mulvey and Simor 2009). Horizontal gene transfer is the main mechanism 
that permits the acquisition and dissemination of antibiotic resistance genes. Thus, the 
rapid emergence of antibiotic resistance genes occur due to mobile genetics structures, 
such as plasmids, transposons and insertion sequence common regions (ISCR), which 
permit that opportunists bacteria become multi-drug resistance (MDR) (Bennett 2008). 
Class 1 integrons were the first type integrons to be described (H. W. Stokes 1989), 
and constitute the most intensively studied group to date. These elements are found in 
40 to 70% of Gram-negative pathogens isolated from clinical contexts, and at similar 
frequencies in pathogens and commensals isolated from livestock. The rapid emergence 
of these structures in Gram-negative and, more recently in Gram-positive bacteria, have 
been facilitated by their location on mobile DNA elements, such as plasmid and 
transposons (Gillings, Boucher et al. 2008). Integrons are defined as systems capable of 
capture and express exogenous resistance genes. Usually, they are composed by two 
conserved segments (5’-CS and 3’-CS) that limit a variable region (VR) containing genes 
cassette, which confer resistance to different classes of antibiotics. The integration or 
excision of these cassettes is catalyzed by integrase enzyme (IntI) and by a primary 
recombination site, attI, which recombine with the corresponding attC site present in the 
genes cassette (Labbate, Case et al. 2009). The expression of these genes is mediated by a 
promoter (Bogaerts, Huang et al.; Simon A. Hardwick 2008). In some integrons, the genes 
that compose the 3’-CS were deleted and downstream of the VR a complete transposition 
of a tni module of the transposon to which the integron found is associated (Gillings, 
Boucher et al. 2008).  
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Recently, a new type of class 1 integron has arisen, and is designed complex class 1 
integrons. This structure is similar to the class 1 integron, but downstream of the sul1 
gene in the 3’-CS, an ISCR1 is present followed by a second VR that terminate in a 
repeated copy of 3’-CS (Quiroga, Andres et al. 2007).   
β–lactamases enzymes are associated to the inactivation or hydrolysis of the β-
lactams antibiotics. These enzymes can be divided in extended spectrum β – lactamases 
(ESBLs) (mainly TEM, SHV, CTX and OXA types), which confer resistance to penicillins, the 
majority of the cephalosporins and aztreonam (T. Naas 2008); or metallo-β-lactamases 
(MBLs) (mainly VIM and IMP types), which confer resistance to majority of β-lactam 
antibiotics, including carbapenems. ESBLs are present mainly in plasmids and 
transposons, although OXA and CTX-M can arise in complex class 1 integrons, integrated 
in a second VR (Sacha, Wieczorek et al. 2008). VIM and IMP types emerged mainly 
associated to integrons that can be embedded in transposons. Due to their location, 
these enzymes are quickly disseminated between different bacterial species worldwide 
(Libisch, Watine et al. 2008). 
Molecular methods are essential to study the epidemiology of bacterial isolates, and 
to determine the resistance determinants associated to mobile genetic elements such as 
integrons and β-lactamases enzymes. Polimerase chain reaction (PCR) is usually employed 
to amplify the genetically important resistance genes. Pulsed-field gel electrophoresis 
(PFGE) was employed to locate the most important integrons. PCR-associated to typing 
methods such as BOX-PCR, was used to distinguish between different strains of the same 
species, since it is based in repetitive and conserved sequences that are present in the 
bacterial genome. 
Here, we investigate the prevalence of the antibiotic resistant determinants, such as 
class 1 integrons and β–lactamases enzymes in Gram-negative isolates collected from 
inanimate surfaces of a female ward sanitary facility (doorknob, sink and toilet) in the 
Hospital Infante D. Pedro. 
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3. MATERIALS AND METHODS 
 
3.1 Bacterial strain selection and antibiotic susceptibility determination 
 
Sterile cotton swabs were rubbed in the surfaces (doorknob, sink and toilet) of a 
female ward sanitary facility and incubated in the liquid rich medium tryptone soya broth 
(TSB) at 37°C for 24 hours. Serial dilutions were made and inoculated in a selective 
medium, MacConkey agar, for Gram-negative isolates. rep-PCR was performed to 
distinguish bacteria by clonality. Gram-negative isolates were selected for further 
characterization studies. Those strains were identified using the automatic VITEK 2 
system and Advanced Expert System (VITEK 2 AES) (BioMérieux, Marcy L´Étoile, France) 
and confirmed by 16S rDNA sequence (Martinez-Freijo, Fluit et al. 1998). Susceptibility 
testing was carried out according to guidelines of CLSI standards (2006) and different 
antibiotics were used, such as aztreonam, amoxicillin/clavulanic acid, ampicillin, 
piperacillin/tazobactam, cefotaxime, ceftazidime, cefuroxime, imipenem, meropenem, 
gentamicin, ciprofloxacin, norfloxacin, tobramycin, trimethoprim-sulfamethoxazole. 
Species found included Escherichia coli, Pseudomonas aeruginosa, Pseudomonas 
putida, Pseudomonas mendocina, Enterobacter cloacae, Citrobacter freudii, Citrobacter 
braakii, Klebsiella pneumonia, Proeteus mirabilis, Stenotrophomonas maltophilia, Serratia 
liquefaciens, Morganella morganii, Alcaligenes xylosoxidans and Acinetobacter 
baumannii.  
 
 
3.2 Molecular typing: rep-PCR technique 
 
rep-PCR was employed to evaluate the clonal relationship between the isolates, 
decreasing the initial study population. Genomic DNA profiles were obtained by BOX-PCR 
using the specific primer, BOXA1R (BRUIJN 1997).  
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After electrophoresis, distinct banding pattern was analyzed with the Gel Compar II 
software (Applied Maths, Kortrijk, Belgium), which allowed the construction of a 
phylogenetic tree to distinguish different clonal group. 
 
 
3.3 Screening of integrase class 1 and class 2 integron and amplification of variable 
region 
 
Screening for the intI1 gene was performed using the specific primers HS464 and 
HS463a and for the intI2 were used RB201 and RB202 (Barlow, Pemberton et al. 2004). In 
the strains that were positive for this gene, their VR was further amplified with specific 
primers (Barlow, Pemberton et al. 2004). In a P. putida strain, the VR was not amplified 
with the usual primers, but could be amplified with the primers RB317 and TniC 
(Toleman, Vinodh et al. 2007). By primer walking all the genes cassette present were 
characterized.  
PCR amplifications were carried out in 12,5 – 50 µl volumes containing 1 µl of 
template DNA and a mix with MgCl2+ (3.0 mM), buffer NH4+ (10X), dNTPs (0,4 mM) and 
Taq polimerase (0.02 U).  
In general, PCR conditions consisted of an initial cycle of 4’ at 94°C; followed 30 cycles 
of 30’’ at 94°C; 30’’ at an annealing temperature of 65°C and 59°C for intI1 gene and for 
VR, respectively; and 72°C, 45’’ for integrase and 3’30’’ for VR; followed a final extension 
cycle at 72°C during 5’ and 10’, for integrase and VR, respectively. Annealing temperature 
and extension time depended on the length of the genes to amplify.  
 
 
3.4 Screening of ESBLs and MBLs enzymes 
 
ESBLs (CTX-M, SHV, TEM and OXA) and MBLs (VIM and IMP) genes were amplified 
with specific primers (Henriques, Fonseca et al. 2006).  
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The PCR programme was similar to that employed for the amplification of the intI1 
gene, but the annealing temperature varied according to the enzyme type (TEM: 44°C, 
SHV: 62°C, CTX-M: 55°C, OXA: 53°C, VIM: 58°C and IMP: 55°C). The period of extension 
was 45’’ for all enzymes.  
 
 
3.5 DNA sequencing of the antibiotic resistant determinants  
 
The amplicons were purified with the QIAquick PCR purification kit (QIAGEN, 
Germany) and both DNA strands were sequenced by StabVida company. Subsequently 
nucleotide and amino acid sequences were analyzed and compared with those available 
in the GenBank database using the basic local alignment search tool (Blast and ClustalW 
computer programs). 
 
 
4. RESULTS  
 
4.1 Molecular typing 
 
By BOX-PCR technique is was possible to reduce the bacterial population to be 
studied. The analysis of the banding pattern profiles permitted the construction of a 
phylogenetic tree, using the GelCompar II software (Applied Maths, Kortrijk, Belgium). 
Analysis of the phylogenetic tree allowed distinguishing between the different clonal 
groups (data not shown). From those, only forty-five isolates of a total of eighty-five were 
selected for the present study. 
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4.2 MICs profiles 
 
The MICs profiles were determined by antibiotic disks. The forty-five isolates revealed 
a higher resistance level to ampicillin and amoxicillin/clavulanic acid (β-lactam 
antibiotics), which belong to penicillins family.  
Since they were the first antibiotics to be introduced and therefore have been 
intensively used for the treatment of bacterial infections, the majority of bacteria 
developed resistance to them. Only two species, A. xylosoxidans and S. maltophilia, are 
sensitive to these antibiotics, while E. coli, E. cloacae and K. pneumoniae strains show a 
high percentage of resistance to these compounds. Moreover, resistance to the 
carbapenems (imipenem and meropenem) and monobactams (aztreonam) was only 
observed in Pseudomonas spp. (Figure 15).    
 
 
 
 
Figure 15 – Percentage of resistance profiles present in the eighty-five isolates. β-lactams 
antibiotics: ATM, aztreonam; AMC, amoxicillin/clavulanic acid; AMP, ampicillin; TZP, 
piperacillin/tazobactam CTX, cefotaxime; CAZ, ceftazidime; CAS, cefuroxime; IPM, imipenem; 
MEM, meropenem; and non β-lactams antibiotics: GEN, gentamicin; CIP, ciprofloxacin; NOR, 
norfloxacin; TOB, tobramycin; SXT, trimethoprim-sulfamethoxazole. 
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4.3 Detection of class 1 integrons 
 
PCR specific for the intI1 gene revealed the presence of class 1 integrons in 33,33% of 
the isolates (15 different arrays in 45 isolates). These structures were detected in 20% of 
Escherichia coli (3/15), 13% of P. aeruginosa (2/15), 20% of P. putida (3/15), 7% of P. 
mendocina (1/15), 14% of K. pneumonia (2/15), 13% of M. morganii (2/15) and 20% of P. 
mirabilis (2/15) isolates (Figure 16).  
 
 
           
 
Figure 16 – Percentage of isolates that carry class 1 integrons, and the percentage of these 
structures present in each bacterial specie. 
 
 
4.4 Characterization of the variable region  
 
VRs were characterized in all the intI1 gene positive strains. The amplicon lengths 
corresponding to the sizes of the VRs varied from 900 bp to approximately 4200 bp, 
indicating heterogeneity of the genes cassette (Table 4). No class 2 integrons were 
detected. 
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In the present work were found 15 different arrays, of which 47% correspond to novel 
combinations of genes cassette (7/15), never described before; and 53% were already 
described in different countries and species (8/15), but in biological samples from 
patients or animals. 
 
All class 1 integrons found in E. coli isolates have been previously described, in 
different geographic locations (Peters, Leverstein-van Hall et al. 2001; Ahmed, Miyoshi et 
al. 2005; Bae, Lee et al. 2007; Osman Birol Ozgumus 2007; Il Kwon, Yong Hwan et al. 
2008; Kadlec and Schwarz 2008; Ajiboye, Solberg et al. 2009).  
 
In99 described by Caetano et al. (Caetano, Ferreira et al. 2007) was found in P. 
aeruginosa; in M. morganii a new array was found in Portugal (EU430601), however it has 
already been described in the same species from Malaysia (unpublished); in P. putida an 
In58 was found consisting in the first description of this integron in Portugal and in the 
species (FJ548856). Nevertheless, this array was described in a P. aeruginosa from France 
(AF263520). All the other arrays found and described in this study are novel and gene 
sequences were deposited in GenBank (Table 4).  
 
In a P. putida isolate, a tniC gene was found in place of the 3’-CS. Downstream of the 
VR a gene corresponding to the transposon where the integron is associated was found. 
In this case the fusion qacEΔ1/sul1 was deleted, maybe due to the discontinued use of 
quaternary ammonium compounds and sulphonamides, respectively (submitted). 
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Table 3 – Gene cassette arrays found in class 1 integron-positive bacterial strains and respective 
length and accession number.  
 
Bacterial 
specie 
Cassette arrays Approximat
e length (bp) 
GenBank 
no. 
 
E. coli 
aadA2 1200 Described 
in different 
countries 
dhfr1 / aadA1 1900 
dhfr12 / ORF F / aadA2 2100 
 
K. pneumoniae 
arr-3 / dfrA27 / aadA16 
aac(6’)-Ib / blaOXA-30 / catB3 / arr-3 
VR1: 2600 
VR2: 7000 
FJ459817 
dhfrA15 / aadA1 1900 FJ232919 
P. aeruginosa aacA4 / blaP1b / aadA2     (In99) 3000 Portugal 
aacA4 / VIM-2 / aacA4 / aadA1 3500 FJ532358 
 
P. putida 
aacA4 / VIM-2 / aac(6’)-IIc/tnpA/aac(6’)-IIc 4200 FJ715942 
aacA7 / VIM-2 / aacC1 / aacA4     
(In58) 
3200 FJ548856 
(France) 
VIM-2 / ORF-1 (tniC) 2000 FJ237530 
P. mendocina IMP-8 / aacA4 / aadA1 / tnpA 4100 FJ594416 
P. mirabillis aacC1 900 EU851865 
dhfrVII 1000 EU860402 
M. morganii blaP1b / aadA2 2200 EU430602 
aadB / catB3 1700 Malaysia 
 
 
Overall, the VR present found are composed mainly by genes cassette that confer 
resistance to aminoglycosides (54%) (aminoglycoside-acetyltransferase – aac gene and 
aminoglycoside-adenylyltransferase – aad gene), followed by genes cassette that confer 
resistance to trimethoprim (dihydrofolate reductase – dhfr gene), present in 14% of the 
arrays. Other genes cassette such as oxacillinase (blaOXA-30 gene), is present only in one 
array in K. pneumoniae (2%), while a putative transposase (tnpA gene), proteins unknown 
function (ORFs), rifampin ADP-ribosylating transferase (arr gene) and cloramphenicol 
acetyltransferase (cat gene) appear in only 3 % of the arrays (Figure 17). 
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Figure 17 – Representation of all genes cassette found in the different arrays of class 1 integrons 
amplified. 
 
 
4.5 Detection and analysis of β – lactamases enzymes gene sequences 
 
Although many ESBL-encoding genes have been described in the literature, only a few 
of these (namely blaTEM, blaSHV, blaOXA and blaCTX) were detected by PCR and confirmed by 
nucleotide sequencing. The sequences of the amplicons, when compared with others 
deposited in the database, revealed that TEM-1, SHV-12, OXA-30, CTX-M-15, VIM-2 and 
IMP-8 were predominant in the different strains. 
According to the Figure 18, TEM type was the most prevalent gene (66%), and was 
present in all the studied species, except S. liquefaciens, followed by SHV type (16%) that 
was present in E. coli, K. pneumonia and E. cloacae isolates. MBLs (VIM and IMP types), 
appeared only in some Pseudomonas spp. in a lower percentage, and are associated to 
the VR of the class 1 integrons.  
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Figure 18 – Percentages of the β-lactamases enzymes found in the forty-five studied isolates. 
 
 
4.6 Relationship between MICs profile, class 1 integron and β-lactamases enzymes 
 
In order to confirm the effect of class 1 integron carriage (Table 4) and β-lactamases 
enzymes exhibited by the bacteria, we analysed the MIC data of integron positive bacteria 
with the cassette arrays. Thus, according to Figure 15, almost all intI1 positive isolates 
show high resistance to ampicillin (19%) and cephalosporins (19%), that can be justified 
by presence of TEM-1 or SHV-12 (in some isolates) and CTX-M-15 and OXA-30 (in E. coli 
and K. pneumoniae isolates), respectively. The Pseudomonas spp. isolates are the unique 
that possess gene sequences that produce MBLs enzymes (VIM-2 and IMP-8) (4%), which 
confer resistance to carbapenems. The resistance to aminoglycosides (12%) predominate 
in class 1 integrons-positive isolates, and could be related to the presence of aad and aac 
genes cassette present in the VR. Resistance to trimethoprim and sulphonamides is 
present in 8% of the cassettes, and can be due to dhfr and sul1 genes, respectively. 
Resistance to quinolones (16%) can not be associated to any gene present in the VR. 
However it can probably due to the presence efflux pumps or mutations in gyr or par 
genes. 
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Analysing of all the cassette arrays here described (Table 4). It is possible to identify 
only one MDR isolate, a K. pneumoniae strain with a complex class 1 integron. This isolate 
shows resistance to rifampicin (conferred by arr-3 gene), trimethoprim (conferred by 
dfrA27 gene), aminoglycosides (conferred by aadA27 gene), some β-lactams antibiotics 
(conferred by blaOXA-30 gene), quinolones (conferred by aac(6’)-Ib-cr gene) and 
cloramphenicol (conferred by catB3 gene). All other arrays relate to resistance for only to 
one or two classes of antibiotics.  
 
In those isolates where MIC values suggest a multi-resistance profile, this is not only 
due to the presence of integrons or β-lactamases enzymes but it can be attributed to 
other resistance mechanisms such as mutations or the presence of efflux pumps. 
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5. DISCUSSION 
 
All isolates collected in the hospital environment were opportunistic bacteria, since 
they are known to be able to infect a host and cause a bacterial infection. An analysis of 
the MIC profiles revealed that 77, 65% of the isolates are MDR (66/85), but the analysis of 
the cassette arrays, only one isolate is MDR (1.18%). The majority of them are resistant to 
β-lactams, mainly ampicillin (19%) and some cephalosporins (19%), and also to other 
classes of antibiotics, such aminoglycosides (12%), quinolones (16%) and trimethoprim-
sulfametoxazole (8%). Resistance to aztreonam (3%) and carbapenems (4%) was also 
observed but only in Pseudomonas spp. and Strenotrophomonas spp. These percentages 
were expected, since the bacteria are more resistance to the antibiotics commonly used.  
 
Class 1 integrons were detected in 33% of the strains belonging to E. coli, K. 
pneumoniae, Pseudomonas spp., P. mirabilis and M. morganii species. The cassette arrays 
were mainly constituted by genes associated to resistance to the aminoglycosides (54%), 
trimethoprim (14%) and MBLs (10%), although other genes were present in a lower 
percentage. As suggested by other authors, the different size cassettes demonstrates the 
variable nature of these structures, presumably reflecting differences in the number and 
type of inserted genes cassette (Stokes, Nesbo et al. 2006). All the integrons carried at 
least one cassette that conferred resistance to the aminoglycosides (aad or aac genes). 
Similar results were reported by Poirel and their collaborators (Poirel, Lambert et al. 
2001). Concerning the MBLs, VIM-2 and IMP-8 always appeared associated with the VR of 
the Pseudomonas spp. strains. VIM-2 is the most prevalent MBL present worldwide in 
Pseudomonas spp. isolates (Poirel, Naas et al. 2000; Lee, Lim et al. 2002; Guerin, Henegar 
et al. 2005; Lolans, Queenan et al. 2005; Quinteira, Ferreira et al. 2005; Fiett, Baraniak et 
al. 2006; Villegas, Lolans et al. 2006; Gutierrez, Juan et al. 2007; Huang, Chang et al. 2007; 
Walsh and Rogers 2008). Thus, in all isolates, the presence of these genes cassette may 
be responsible by the resistance profile observed as revealed by the MICs values. 
 
 
68 
 
Most of the class 1 integrons here reported are novel, and were never described 
before. Some of them are described for the first time to be detected in a certain species 
and others were detected on Portugal for the first time. However, all the arrays found in 
E. coli isolates have been previously described in different countries, including Portugal 
locations (Peters, Leverstein-van Hall et al. 2001; Ahmed, Miyoshi et al. 2005; Bae, Lee et 
al. 2007; Osman Birol Ozgumus 2007; Il Kwon, Yong Hwan et al. 2008; Kadlec and Schwarz 
2008; Ajiboye, Solberg et al. 2009). These arrays have frequently emerged in different 
species collected from different biological samples (Dalsgaard, Forslund et al. 2000; 
L'AbÃ©e-Lund and SÃ¸rum 2001; Norskov-Lauritsen, Sandvang et al. 2001; Gu, Tong et al. 
2007; Wiesner, Zaidi et al. 2009) 
 
In99 was found in P. aeruginosa. This same integron was previously described in the 
same species and it was also isolated from an inpatient of the same hospital in 2003 
(Caetano, Ferreira et al. 2007) showing its prevalence and dissemination within this 
environment or in the community. In58 was found in P. putida, however this integron was 
previously described in a P. aeruginosa in France (Poirel, Lambert et al. 2001).  
 
In a P. putida strain a tniC gene appeared in the place of the usual 3’-CS. Recent 
studies also report these findings (Toleman, Vinodh et al. 2007; Gillings, Boucher et al. 
2008). This type of structure was only described in P. aeruginosa from different countries 
(Corvec, Poirel et al. 2008; Samuelsen, Buaro et al. 2009), suggesting the recent evolution 
of these structures. The same structure was also found in a P. aeruginosa strain in Spain 
(unpublished, accession number: GQ422829).  
 
Other interesting array was found in a K. pneumoniae isolate containing a complex 
class 1 integron. This structure is novel in the specie and geographic distribution. 
Nevertheless, the first VR was found in E. coli (Wei Q 2009) and V. cholerae (unpublished; 
accession number: EU678897) isolates from China. The different genes cassette present 
in this complex class 1 integron may be responsible for the MDR profile of this isolate. 
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Since the class 1 integrons are normally associated to MGEs, their dissemination 
between different species within the hospital environment is facilitated, and can cause 
bacterial infections in debilitated patients, compromising the treatment.  
 
A screening for presence of some β-lactamases genes was also performed revealing 
that ESBLs are the most prevalent enzymes (91%) and are present in all species. Most of 
them were of the TEM-1 type (66%). With the exception of blaCTX-M-9 and blaOXA-30 that can 
be found in class 1 integrons (Poirel, Lambert et al. 2001), frequently ESBLs appear 
associated with plasmids therefore its high dissemination is not directly related to class 1 
integrons (Machado, Ferreira et al. 2007). These genes are responsible mainly for the 
resistance to penicillins and their derivates, and some cephalosporins. MBLs are less 
abundant (9%) and were only present in class 1 integrons found in Pseudomonas spp. 
isolates. Since these genes are placed in integrons that are associated with other MGE, 
the rate of dissemination of these genes is greater.   
 
Overall the results show that, as expected given the high selective pressure, the 
emergence and prevalence of antibiotic resistance among bacteria colonizing the hospital 
environment is high, and it appears to be disseminated by different opportunistic species 
that become MDR and are able to cause infections in inpatients. This hypothesis is 
supported by other studies performed worldwide, in which different Gram-negative 
bacteria isolated from various biological samples contain similar class 1 integrons and β-
lactamases enzymes (Poirel, Lambert et al. 2001; Quinteira, Sousa et al. 2005; Gu, Tong et 
al. 2007; Kadlec and Schwarz 2008; Ajiboye, Solberg et al. 2009; Wei Q 2009). 
 
Thus, this surveillance studies are very important since the information provided 
constitute an alert and can contribute to the implementation of new guidelines within the 
hospital environment. 
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1. ABSTRACT 
 
Three Pseudomonas putida strains containing blaVIM-2 gene were isolated from an 
inanimate surface of a female ward sanitary facility in the Hospital Infante D. Pedro, 
Aveiro. Novel class 1 integron was found in strain Pp2. Strain Pp1 carries a class 1 integron 
firstly described in this species. Those integrons are located on plasmids as revealed by 
Southern blot hybridization with intI1 and 16S rRNA DIG labeled probes. PFi strain carries 
a class 1 integron associated with a Tn5090-like transposon, constituting the first report 
of this type of arrangement in a strain from Portugal. 
 
 
Keywords 
Class 1 integrons, TniC-like transposon, Pseudomonas putida, inanimate surfaces 
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2. DESCRIPTION  
 
Pseudomonas putida is a Gram negative opportunistic pathogen that is rarely 
involved in human infections, (Poirel, Cabanne et al. 2006) and is therefore considered as 
a low-grade pathogen (Corvec, Poirel et al. 2008; Sacha, Wieczorek et al. 2008; Walsh and 
Rogers 2008).  
Carbapenems are broad spectrum antibiotics that are frequently used in the 
treatment of Pseudomonas spp. infections (Walsh and Rogers 2008). Consequently, the 
emergence of metallo-β-lactamases (MBLs) of IMP or VIM type among non-fermenting 
Gram-negative bacteria is becoming frequent and represents an epidemiological risk since 
these enzymes confer resistance not only to carbapenems, but virtually to all β-lactams 
(Bebrone 2007; Sacha, Wieczorek et al. 2008). Moreover, blaIMP and blaVIM genes are 
usually carried on integrons, in association with aminoglycosides cassettes. These mobile 
elements are easily spread horizontally between different species due to their association 
with transposons or plasmids (Walsh 2005; Bebrone 2007; Libisch, Watine et al. 2008; 
Sacha, Wieczorek et al. 2008). 
blaVIM-2 was first described in a Pseudomonas aeruginosa (Poirel, Naas et al. 2000) 
isolated in France. Presently, the VIM type enzymes are the second dominant group of β-
lactamases, and it has been reported in different species from 23 countries worldwide 
(Walsh, Toleman et al. 2005; Sacha, Wieczorek et al. 2008), with the alleged “index” strain 
being a Portuguese P. aeruginosa isolate recovered in 1995 (Toleman, Vinodh et al. 2007; 
Cardoso, Alves et al. 2008). The presence of VIM-2 enzymes in this species was originally 
restricted to East Asia,  but recently it has been found in Latin America (Buenos Aires) 
(Almuzara, Radice et al. 2007) and Europe (Belgium) (Bogaerts, Huang et al. 2008).  
 
Here we report and characterize three novel class 1 integrons found in P. putida 
strains from Portugal. Particular emphasis is given to the integron found associated to the 
Tn5090-like transposon.  
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During an infection control study in 2005, three strains of P. putida (PFi, Pp1 and Pp2) 
were isolated from different surfaces within a female ward sanitary facility (doorknob, 
sink and toilet: Pp1, Pp2 and PFi isolates, respectively) in the Hospital Infante D. Pedro, 
Aveiro. The strains were identified by 16S rDNA sequencing. Antibiotic susceptibilities 
(Table 5) were determined according to guidelines of CLSI standards (CLSI 2006). MBL 
production was investigated by Etest MBL with Imipenem/Imipenem+EDTA strips 
according to manufacturer’s instructions (AB BioMérieux, Solna, Sweden).  
 
 
Table 4 – MICs profiles for P. putida Pp1, P. putida Pp2 and P. putida PFi, determined according to 
guidelines of CLSI standards. 
 
Antibiotic 
MIC (µg/mL) 
Pp1 Pp2 PFi 
Ceftazidime 64 16 64 
Cefepime 64 8 16 
Cefpirome 64 32 64 
Aztreonam 64 16 64 
Imipenem 16 16 16 
Meropenem 16 16 16 
Amikacin 16 2 4 
Gentamicin 16 1 1 
Isepamicin 64 1 1 
Netilmicin 32 1 2 
Tobramycin 16 1 1 
Colistin 0.5 0.5 0.5 
Trimetoprim/Sulfametoxazol 320 320 320 
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The presence of blaVIM and blaIMP genes was confirmed by PCR as previously 
described by Henriques et al. (Henriques, Fonseca et al. 2006); only blaVIM gene could be 
amplified; subsequently nucleotide sequencing analysis confirmed the blaVIM-2 variant in 
the three strains. In Pp1 and Pp2 isolates, a variable region of 3800 bp and 3000 bp, 
respectively, was amplified corresponding to a unique and novel array of genes cassette, 
never described before in P. putida (Figure 19). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: (A) Schematic representation of P. putida integrons reported in this study; (B) 
Schematic representation of P. aeruginosa tniC-integrons previously found (adapted from 
Toleman et al. (Toleman, Vinodh et al. 2007). The genes cassette are represented by boxed 
arrows indicating the transcriptional orientation. A white circle represents the attI1 site and the 
black circles represent the genes cassette recombination site, attC or 59-be. 
 
 
(A) 
(B) 
Pp2 
qac∆E1 sul1 blaVIM-2 intI1 aacA4 tnpA  aac6’-IIc 
intI1 aacA7 blaVIM-2    aacA4 qac∆E1 sul1 
Pp1 
aacC1 
intI1 blaVIM-2    ORF-1 tniC PFi 
USA, Russia, 
Norway and 
Taiwan integron  
intI1 aacA7 blaVIM-2 dhfrB5 
 
   aacC-A5 tniC 
India 
integron tniC 
intI1 aacA7 blaVIM-2 dhfrB5 
 
   aacC6-II      ISPa21 
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 In Pp1 isolate three aminoglycosides resistance genes were found (aacA7, aacC1 
and aacA4) in addition to the blaVIM-2 (Figure 19). This integron is identical to In58, 
originally described in a P. aeruginosa collected in 1998 from Paris (Poirel, Lambert et al. 
2001), and have been found worldwide, including in Portugal, but it was never described 
in P. putida. A similar structure was previously described in P. putida isolates from Korea, 
however the order of the two first genes cassette is inverted, and the third gene is 
different (Lee, Lim et al. 2002).  
  
 Pp2 integron contains four genes within the variable region (Figure 19). The first 
position is occupied by an aminoglycoside (6') acetyltransferase gene (aacA4), followed 
by the MBL gene blaVIM-2. These genes are frequently found associated in several class 1 
integrons. In the third position an aminoglycoside 6'-N-acetyltransferase gene (aac(6’)-IIc) 
is found disrupted by an insertion sequence IS1382. This insertion sequence when 
associated with different antibiotic resistance genes can play an important role in their 
dissemination. IS1382 is composed by a putative transposase gene (tnpA) flanked by two 
35 bp inverted repeats; it was detected in other P. putida strains and it is located either in 
a plasmid or in the chromosome (AF052750 and CP000949, respectively).  
  
 Amplification of a variable region of the integron found in PFi strain was 
unsuccessful. Therefore the substitution of the qacE∆1/sul1 by tniC gene was 
investigated. A variable region of approximately 2000 bp was amplified using 5CS/tniCF 
primers previously described (Toleman, Vinodh et al. 2007), confirming the presence of 
tniC gene. This structure has never been described before in P. putida. Nucleotide 
sequence determination revealed the presence of the blaVIM-2 gene, followed by an ORF1 
of unknown function. Moreover, the predicted arrangement of genes is different from 
previously described tniC-like integrons found in P. aeruginosa strains isolated from India, 
Russia, United states (Toleman, Vinodh et al. 2007), Norway (Samuelsen, Buaro et al. 
2009) and Taiwan (Yan, Hsueh et al. 2006). 
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 The blaVIM-2 gene cassette found in these integrons may be responsible for the 
resistance to imipenem (≥ 16 µg/ml) and meropenem (≥ 16 µg/ml) in all isolates. 
According MIC profile of the Pp1 isolate, resistance to aminoglycosides (≥ 16 µg/ml ) can 
be due to aacA7, aacC1 and aacA4 gene cassettes. However, in Pp2 isolate gentamicin (≥ 
1 µg/ml) resistance is not observed despite the presence of aacA4 gene cassette, and 
netilmicin and tobramycin (≥ 1 µg/ml) resistance was not expected since aac(6’)-IIc gene 
is disrupted  by the tnpA gene, rendering this gene inactivate. As suggested by other 
authors in similar studies where the same results were observed, other mechanisms, such 
as antibiotic target modification or over-expression of efflux systems can contribute for 
the multi-resistant phenotype of these isolates (Tenover 2006; Mulvey and Simor 2009). 
 
The location of the integrons was investigated by pulsed-field gel electrophoresis 
(PFGE). Genomic DNA plugs were digested by S1 (New England biolabs, Beverly, Mass.), 
separated on an 1% agarose gel with a CHEF-DRIII system (Bio-Rad, Hemel Hempstead, 
UK), and hybridized to labeled 16S rDNA and intI1 probes. The results obtained for Pp1 
and Pp2 strains suggest that both integrons are located on plasmids (Figure 20). The 
location of the PFi integron could not be determined by both hybridization of S1-PFGE 
digests and plasmid alkaline lysis extraction.  
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Figure 20: Hybridization with DIG labelled intI1 (A) and 16S rDNA (B) probes of S1 digested 
genomic DNA of three P. putida isolates (Pp1, PFi and Pp2) DNA after separation in PFGE. Lane M: 
DNA size marker (λ concactamers); arrows indicate hybridizion signals. 
 
 
Recently multi-resistant P. putida have been associated with difficult-to-treat 
infections (Almuzara, Radice et al. 2007; Bogaerts, Huang et al. 2008; Bennett, Herrera et 
al. 2009). This study demonstrates that despite the uncommon association of multi-
resistant P. putida with human infections within the hospital environment this bacterium 
can act as a reservoir for antibiotic resistance genes, highlighting its potential as an 
emerging nosocomial pathogen.  More worrying is the fact that these genes are placed in 
mobile elements, namely the blaVIM-2 that was found associated with the TniC-like 
transposon, promoting their dissemination among other pathogens within this highly 
selective environment.  
 
The nucleotide sequences reported in this paper are deposited in the GenBank 
under the accession numbers FJ237530, FJ548856 and FJ715942. 
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1. ABSTRACT 
 
A Pseudomonas mendocina carrying a novel class 1 integron containing an IMP-8 
metallo-β-lactamase was isolated from an inanimate surface of a female ward sanitary 
facility in the Hospital Infante D. Pedro, Aveiro, Portugal. The integron is chromosomally 
located as revealed by Southern blotting hybridization with integrase gene (intI1) and 16S 
rDNA.  
Here we report for the first time the presence of an IMP-8 metallo-β-lactamase gene 
in the Pseudomonas genera. 
 
 
Keywords 
Class 1 integron, IMP-8 metallo-β-lactamase, Hospital environment 
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2. INTRODUCTION 
 
Pseudomonas mendocina is a Gram-negative environmental bacterium that can cause 
opportunistic nosocomial infections, such as infective endocarditis and spondylodiscitis 
(Mert, Yilmaz et al. 2007).  
The ability of bacteria to develop resistance is impressive as observed by the arising of 
multiresistant bacteria. For instance, the emergence of metallo-β-lactamases (MBLs), 
mainly VIM and IMP types, conferring resistance to the carbapenems, except 
monobactams is increasing worldwide. Consequently, carbapenems are becoming less 
effective in the treatment of Gram-negative rods infections carrying these enzymes 
(Bebrone 2007).  
IMP-1 was the first mobile MBL isolated and characterized from a Japanese P. 
aeruginosa strain in 1988 (Docquier, Riccio et al. 2003; Sacha, Wieczorek et al. 2008). The 
blaIMP gene is worldwide distributed (Sacha, Zórawski et al. 2007) and is commonly found 
associated with class 1 or class 3 integrons (Toleman, Biedenbach et al. 2003), that are 
located in large plasmids (Shibata, Doi et al. 2003), contributing to its rapid dissemination 
through horizontal gene transfer both from cell to cell and between DNA molecules. IMP 
producers, usually Gram-negative pathogens, have been reported in nosocomial 
outbreaks during the last few years (Pagani, Colinon et al. 2005). blaIMP-8 is a variant of the 
blaIMP-2 gene; it was firstly described in a Klebsiella pneumoniae strain from Taiwan in 
1998 (Yan, Ko et al. 2001). Both genes differ in four nucleotides, resulting in two amino 
acid changes in the final enzymes (Weldhagen 2004; Sacha, Wieczorek et al. 2008).  
Recently, blaIMP-8 was found in some Gram-negative isolates, such as Acinetobacter 
phenon (Wang, Guo et al. 2007), Klebsiella pneumoniae (Yan, Ko et al. 2001; Yan, Ko et al. 
2001), Serratia marcescens and Enterobacter cloacae (Lee, Peng et al. 2008), but it has 
never been identified in Pseudomonas spp. 
 
Here we report and characterize a class 1 integron containing a blaIMP-8 as part of a 
new gene array found in a P. mendocina strain, isolated within the hospital environment. 
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3. MATERIALS and METHODS 
 
a. Bacterial strains and antibiotic susceptibilities  
 
During an infection control study carried out in 2005, a P. mendocina (Pm1) strain was 
collected from an inanimate surface from a female ward sanitary facility in the Hospital 
Infante D. Pedro, Aveiro. The strain was identified by the automatic VITEK 2 and 
Advanced Expert System (VITEK 2 AES) (BioMérieux, Marcy L´Étoile, France). Antibiotic 
susceptibilities were determined according to guidelines of CLSI standards (CLSI 2006). 
Further confirmation at species level was performed by 16S rDNA sequencing.  
 
 
b. Detection and characterization of class 1 integrons 
 
Screening for antibiotic resistance determinants associated with integrons using the 
primers for intI1 gene (Barlow, Pemberton et al. 2004). The corresponding variable region 
was amplified with the primers for intI1 and qacEΔ genes. Resulting in an amplicon, that 
was sequenced. Nucleotide and deduced aminoacid sequences were analyzed with Blast 
and ClustalW programs and compared with others deposited in databases. 
 
 
c. Location of the class 1 integron 
 
The genetic location of the class 1 integron was investigated by S1-Pulsed-Field Gel 
Electrophoresis (PFGE). Briefly, the agarose plugs were prepared as described by 
Samuelsen (Samuelsen, Naseer et al. 2009), and digested with S1 enzyme (New England 
biolabs, Beverly, Mass.). The fragments were separated during 12h using a CHEF-DRIII 
system (Bio-Rad, Hemel Hempstead, UK), transferred to nylon membranes and hybridized 
with 16S rDNA and intI1 DIG labeled probes (Roche, Germany). 
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4. RESULTS and DISCUSSION 
 
Screening for integrons in P. mendocina (Pm1) revealed the presence of a class 1 
integron with a variable region of 4000 bp. By primer walking a blaIMP-8 gene was found 
located near the intI1 followed by aac(6’)-Ib/aacA4 gene (encoding for the 
aminoglycoside-(6')-N-acetyltransferase) and by an aadA1 gene (encoding for a 3''-
adenyltransferase) conferring resistance to the aminoglycosides. The last position, was 
occupied by a putative transposase (tnpA) that usually appears upstream of integrase 
gene, and is usually associated with different transposons (Tseng, Hsueh et al. 2007) 
(Figure 21).  
 
 
 
Figure 21 – Structure of P. mendocina (Pm1) integron and genetic context of other blaIMP-8-
containing class 1 integrons found worldwide. 
 
 
All the class 1 integrons described so far containing blaIMP-8 (Figure 21) possess the 
MBL gene in the first position of the array followed by an aminoglycoside resistance gene, 
usually the aacA4 gene (Yan, Ko et al. 2001; Pagani, Colinon et al. 2005; Lee, Peng et al. 
2008). In Pm1 strain, after the aacA4 gene an aadA1 gene is found, therefore it is not 
possible to establish a possible evolutionary relationship between the integron found in 
Pm1 and the other previously described structures harboring this blaIMP allele. Moreover, 
this is the first study reporting the occurrence of blaIMP-8 in the Pseudomonas genera.  
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Analysis of Pm1 resistance profile (Table 6) shows a reduced susceptibility to 
imipenem (MIC ≤ 4 µg/ml), and susceptibility to meropenem (MIC ≤ 1 µg/ml). The 
presence of the blaIMP-8 gene in this strain, might contribute to the MIC value observed for 
imipenem. However, the evaluation of MBL production by Etest with 
Imipenem/Imipenem + EDTA strips (AB BioMérieux, Solna, Sweden) was negative. These 
results highlight the difficulty to detect IMP-8 enzymes by routine susceptibility tests, a 
problem also referred by others authors (Yan, Ko et al. 2001). 
 
Consequently, a combination of phenotypic and molecular biology techniques applied 
to determination of carbapenemase activity could be employed to provide more reliable 
results for epidemiological studies and also for patients treatment (Yan, Ko et al. 2001). 
 
 
Table 5 - MICs profile of P. mendocina Pm1 determined according to guidelines of CLSI standards. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antibiotic 
MICs 
(µg/ml) 
Ceftazidime 64 
Cefepime 64 
Cefpiroma 64 
Aztreonam 4 
Imipenem 4 
Meropenem 1 
Amicacin 2 
Gentamicin 4 
Colistin 0.5 
Trimetoprim/Sulfametoxazol 320 
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According to the S1-PFGE southern blot, identical results were obtained with 16S 
rDNA and intI1 probes (Figure 22), suggesting a chromosomal location of the integron, 
and consequently of the blaIMP-8 gene. The same location was reported for other MBL 
determinants often present in P. aeruginosa (Nordmann and Poirel 2002), and also with a 
Taiwanese Serratia marcescens clinical strain carrying the blaIMP-8 gene (Lee, Peng et al. 
2008) and an Acinetobacter baumanii possessing a blaIMP-2 as part of a class 1 integron 
(Riccio, Franceschini et al. 2000; Yan, Ko et al. 2001).  
Plasmids are the primary vehicle for horizontal transfer of integron-associated MBL 
responsible for much of the movement of carbapenem resistance genes among 
Enterobacteriaceae and other Gram-negative bacteria (Lee, Peng et al. 2008). Therefore, 
the genomic location of Pm1 integron suggests that its dissemination process will 
probably involve integration catalyzed by transposition, mainly through transduction and 
transformation. Since this isolate is part of the hospital environment, it can play a role of 
donor of such resistance genes to potential pathogenic strains. 
 
 
Figure 22 – Hybridization with DIG labelled intI1 (A) and 16S rDNA (B) probes of S1 digested 
genomic DNA of P. mendocina Pm1 after separation by PFGE. Lane M: DNA size markers (λ 
concactamers). 
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P. mendocina was collected from the surface of a toilet and can therefore easily infect 
debilitated patients, despite the fact that infections caused by this species are rare. Still, 
given its resistance profile, it may pose a risk for patients mainly when responsible for 
infections that are difficult to treat. 
 
The nucleotide sequence reported in this paper is deposited in the GenBank under the 
accession number FJ594416. 
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1. ABSTRACT 
 
A klebsiella pneumoniae isolate (KP1) that was isolated from an inanimate surface of 
a female ward sanitary facility in the Hospital Infante D. Pedro, Aveiro-Portugal, carries a 
novel complex class 1 integron never described before. It contains two variable regions, 
the first was previously described in Escherichia coli and Vibrio cholera; the second 
variable region has an In37-like structure and it is located downstream of the ISCR1. The 
integron is located on a plasmid of 225 Kb, as revealed by Southern blotting hybridization 
with intI1 and 16S rRNA DIG labeled probes. qnrB10 gene is present although not 
associated with the class 1 integron. 
 
 
 
Keywords 
Complex class 1 integron, plasmid location, inanimate surface, Klebsiella pneumoniae  
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2. DESCRIPTION  
 
Klebsiella pneumoniae is an important opportunistic pathogen that causes urinary 
tract and intra-abdominal infections, neonatal meningitis and pneumonia in immune-
compromised individuals (Martin 2007; Thong, Lim et al. 2008). Klebsiellae are 
widespread in the environment and in the intestinal flora of humans and other mammals 
(Martin 2007). 
The extensive use of broad-spectrum antibiotics in hospitalized patients led to the 
development of multi-drug resistance (MDR) strains (Martin 2007). In Klebsiella 
pneumoniae isolates the resistance is due to the production of β-lactamases enzymes, 
mainly extended spectrum β-lactamases (ESBLs) (L. Poirel 2008; T. Naas 2008), but more 
recently metallo-β-lactamases (MBLs) have also been detected (Yan, Ko et al. 2001; 
Bebrone 2007; Lee 2007; Martin 2007). 
Nowadays Klebsiella pneumoniae strains complex class 1 integrons have emerged. 
This new structure is composed by the typical structure of a class 1 integron, associated 
with a new element, designed insertion sequence common region (ISCR1), located 
downstream of the sul1 gene. Immediately after the ISCR1 a second variable region (VR2) 
appears containing resistance genes (β-lactamase, fluoroquinolone, trimethoprim, 
aminoglycoside and cloramphenicol). This region is followed by a repetition of 3’-
conserved segment (3’-CS) (Toleman, Bennett et al. 2006; Bennett 2008; Labbate, 
Chowdhury et al. 2008). Antibiotics such as cephalosporins, β-lactamase-stable penicillins 
and aminoglycosides are commonly used to treat Klebsiella infections, but MDR strains 
may limit the antibiotic choice or compromise the treatment of the infections (Martin 
2007; Chang, Fang et al. 2009). 
 
Here we report and characterize a novel complex class 1 integron in a Klebsiella 
pneumoniae strain collected within the hospital environment in Aveiro, Portugal.  
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During an infection control study in 2005, a K. pneumoniae (Kp1) strain was collected 
from a sink in a female ward sanitary facility in the Hospital Infante D. Pedro, Aveiro. The 
strain was identified by the automatic VITEK 2 and Advanced Expert System (VITEK 2 AES) 
(BioMérieux, Marcy L´Étoile, France), and 16S rDNA sequencing. Additionally antibiotic 
susceptibilities were determined according to guidelines of CLSI standards Table 7 (CLSI 
2006).  
 
Table 6 - MICs for K. pneumoniae KP1, determined according to guidelines of CLSI standards. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The presence of class 1 integrons was investigated using specific primers for intI1 
gene and subsequently to 5’-CS and 3’-CS (Barlow, Pemberton et al. 2004). The first VR 
(VR1) amplified was approximately 3200 bp. By primer walking the complete array of 
genes cassette was determined. Nucleotide sequence analysis revealed a new integron 
Antibiotic MIC (µg/ml) 
Amikacin 2 
Amoxicillin/CA 32 
Ampicillin 32 
Cefotaxime 4 
Ceftazidime 8 
Cephalotin 32 
Ciprofloxacin 4 
Imipenem 4 
Meropenem 2 
Norfloxacin 16 
Piperacillin/Tazobactam 8 
Tobramycin 16 
Trimetoprim/Sulfametoxazol 320 
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structure, never described before in K. pneumoniae, but previously described in 
Escherichia coli (Wei Q 2009) and in a Vibrio cholerae in China (unpublished - EU678897).  
 
The VR of Kp1 isolate was composed by three genes. In the first position, near the 
intI1 gene, was occupied by a rifampin ADP-ribosyl transferase-encoding gene (arr-3), 
followed by a dihydrofolate reductase-encoding gene (dfrA27). The last position was 
occupied by an aminoglycoside-(3’’)(9)-adenylyltransferase (aadA16). An ISCR1 element 
was also amplified that was linked to the class 1 integron. To amplify the VR2, specific 
primers to the ISCR1 and qacEΔ1 were employed resulting in an amplicon of 
approximately 6000 bp. Further sequencing reactions revealed the presence of an array 
consisting of four genes cassette, which constitute the VR of In37 (Figure 23A).  
 
In37 was firstly discovered in a clinical K. pneumoniae isolate from Argentina 
(Quiroga, Andres et al. 2007), and ever since it is described in association with ISCR1 and 
qnr genes (Figure 23B). However, its presence was always detected in the first VR (VR1) 
and never in the VR2, moreover, without an intI1 gene associated.  
 
The resistance observed to sulfamethoxazole, tobramycin, amoxicillin/clavulanic acid 
and cephalotin, could therefore be justified by the genes found in this complex structure. 
Moreover, decreased susceptibility to ciprofloxacin and norfloxacin can be due to other 
mechanisms such as the presence of the qnr genes and efflux pumps. In fact, qnrB10 gene 
was identified in this strain but is not associated with the class 1 integron. qnrB10 gene is 
frequently found linked to the ISCR1 in different class 1 integrons. However in this study 
the attempt to link that association was unsuccessfull, suggesting a new genetic 
environment for this gene (Figure 23C).  
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(A)          K. pneumoniae KP1  
 
 
 
 
 
 
 
 
(B)     K. pneumoniae strain M7943 (Argentina) In37::ISCR1::qnrB6 (Quiroga, Andres et 
al. 2007) 
 
 
 
 
 
 
 
 
             
           E. coli plasmid pHSH2 (China) In37::ISCR1::qnr blaDHA-1 (Wang, Tran et al. 2003) 
 
 
 
 
 
 
 
 
 
qac∆E1 sul1 intI1 qacE∆1 sul1 VR ISCR1 
   qnr blaDHA-1 
VR 
aac(6’)-Ib-cr    catB3 blaOXA-30 arr-3 
intI1 qacE∆1 sul1 
aac(6’)-Ib-cr    catB3 blaOXA-30 arr-3 
VR ISCR1 qac∆E1 sul1    qnrB6 
intI1 
arr-3    aadA16 
qacE∆1 sul1 
dfrA27 
VR ISCR1 VR qac∆E1 sul1 
aac(6’)-Ib-cr    catB3 blaOXA-30 
 
arr-3 
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(C)      E. cloacae strain E705 In131::ISCR1::qnrB10 (Argentina) (Quiroga, Andres et al. 
2007) 
 
 
 
 
 
 
 
                E. cloacae strain E701 In132::ISCR1::qnrB10 (Quiroga, Andres et al. 2007) 
 
 
 
 
 
 
 
Figure 23 - (A) Schematic representation of K. pneumoniae KP1 complex class 1 integron reported 
in this study; (B) Schematic representation of others K. pneumoniae complex class 1 integrons 
previously found worldwide; (C) Genetic environment of the qnrB10 gene in different species. 
The genes cassette are represented by boxed arrows indicating the transcriptional orientation. A 
white circle represents the attI1 site and the black circles represent the genes cassette 
recombination site, attC element. 
 
 
The integron location was investigated by Pulsed-Field Gel Electrophoresis (PFGE). 
Genomic DNA was digested with S1 (New England Biolabs, Beverly, Mass.), separated by 
electrophoresis with a CHEF-DRIII system (Bio-Rad, Hemel Hempstead, UK), and 
hybridized to 16S rDNA and intI1 DIG labeled probes. A positive signal was obtained with 
both probes in different regions of the genomic DNA digested (Figure 24). This result 
intI1 qacE∆1 sul1 
aac(6’)-IId aadA1 
VR ISCR1 qac∆E1 sul1 
   qnrB10 
VR 
   Psp-F 
intI1 qacE∆1 sul1 
aac(6’)-Ib aadA1
VR ISCR1 qac∆E1 sul1    qnrB10 
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reveals that the complex class 1 integron is located in a plasmid with approximately 225 
Kb. Plasmids are the primary vehicles for horizontal resistance gene transfer among 
Gram-negative bacteria (Lee, Peng et al. 2008).  
Transfers of resistance genes by conjugation assays were attempted using E. coli J53 
AzR strain as recipient. Selective media (Mueller-Hinton agar) contained 100 μg/ml sodium 
azide and 0.125 µg/ml ciprofloxacin were used to select E. coli transconjugants (Wang, 
Yang et al. 2008). Recipient strain was resistance to sodium azide and susceptible to 
ciprofloxacin, and Kp1 isolate was resistant to ciprofloxacin (≥ 4 µg/ml). Under the 
laboratory experimental conditions tested, no transconjugants were obtained. 
 
 
 
Figure 24 - Hybridization with DIG labelled intI1 (A) and 16S rDNA (B) probes of S1 digested 
genomic DNA of K. pneumoniae Kp1 after separation by PFGE. Lane M: DNA size markers (λ 
concactamers). 
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This study demonstrates that K. pneumoniae Kp1 can act as a reservoir for antibiotic 
resistance within the hospital environment. The plasmid location of the integron 
represents a threat for the possible dissemination to other species. Since this isolate was 
collected from an inanimate surface of a toilet, and given its resistance profile it can pose 
some risk for debilitated patients, mainly because the infections caused by this 
microorganism are difficult to treat.  
 
The nucleotide sequences reported in this paper is deposited in the GenBank under 
the accession number FJ459817. 
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1. DISCUSSION  
 
Integrons are natural expression vectors that permit the insertion and deletion of 
antibiotic resistance genes by a site-specific recombination mechanism. In the present 
study these structures were found in Enterobacteriaceae (E. coli, K. penumoniae, P. 
mirabilis and M. morganii) and in Pseudomonas spp. strains within the hospital 
environment. Gene cassettes contained within the class 1 integrons, demonstrates an 
association between integron carriage and a reduced susceptibility to some antibiotics 
such as aminoglycosides, trimethoprim and β-lactams. As reported by various authors, 
class 1 integrons have few gene cassettes inserted in the VR (Sally, Guy et al. 2009). In this 
study, this feature is also observed, since the class 1 integrons found in the isolates 
studied contained at the maximum four cassettes. 
 
β-lactamases enzymes were detected in the majority of the isolates; however ESBLs 
are present at a higher percentage and in almost all of the species, while MBLs are only 
present in Pseudomonas spp. strains. According to various authors, this is frequently 
observed since ESBLs inactivate the most frequently used β-lactams, such as penicillins, 
first and second generation cephalosporin (L. Poirel 2008). MBLs are recent enzymes that 
inactivate the carbapenems, which are compounds less used in treatment of bacterial 
diseases. Our results show that in fact there is a relation between antibiotic usage and 
development of resistance mechanisms against that antibiotic as reported before (in page 
10). High levels of resistance where observed to aminoglycosides, penicillins and to the 
first generation cephalosporins. Resistance observed to the other classes of antibiotics 
can be due to different resistance mechanisms such as efflux pumps, mutations and 
alteration in the membrane permeability. 
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The present work is clinically relevant, since it describes the presence of a high 
diversity of resistance determinants in Gram-negative bacteria collected in inanimate 
surfaces that are associated with integrons and β-lactamases. Among these determinants, 
novel arrays were found in different species that encode for enzymes involved in the 
inactivation / degradation of antibiotics. These structures contribute to the selection of 
resistant strains. Moreover these results show that the bacteria can survive and colonize 
different surfaces, remaining in the hospital environment for long periods (Caetano, 
Ferreira et al. 2007). Some of the resistance determinants described in this work are 
already deposited in the Genbank and were described before in isolates collected from 
biological samples of patients and animals. Thus, it may also be suggested that the 
bacteria present in inanimate surfaces can contribute for some of the nosocomial 
infections found, since some genes cassette found in this work were described before in 
biological samples. 
 
In order to evaluate the potential of dissemination of these genetic determinants it is 
important to investigate their genetic location within the genome of the organism. 
Usually, class 1 integrons are associated with other mobile genetic elements, such as 
plasmids and transposons, and therefore can easily disseminate the genes cassette 
among different bacterial species, by HGT (Summers 2006). Moreover, MBLs usually is 
associated to the VR of the class 1 integrons, and therefore their dissemination is 
potentially faster than that of ESBLs, which can be plasmids or chromosomally encoded. 
Given the worldwide flow of people between cities, countries and even continents, 
bacterial clonal dissemination is possible and it became quite frequent to find the similar 
resistance gene array in different geographic locations. Integrons become the major 
contributors to this global problem of spreading antibiotic resistance genes at the clinical 
and environmental level. By these means opportunistic and commensals bacteria can 
become MDR and pathogenic (Stokes, Nesbo et al. 2006). Thus, according other studies 
(Martinez-Freijo, Fluit et al. 1998), the accumulation of resistance genes by integrons and 
the arise of β-lactamases enzymes is one explanation for the emergence of MDR strains 
of Enterobacteriaceae and Pseudomonas spp.. 
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PCR mapping of genes inserted as cassettes into integrons will provide valuable 
information for studies of gene expression as it relates to the position of these genes 
within the integrons (Levesque, Piche et al. 1995). These studies as well as others 
previously described, can be useful epidemiological tools to study the evolution of multi-
resistance plasmids and transposons, dissemination of these antibiotic resistance genes 
and molecular epidemiology of β-lactamases enzymes (Fiett, Baraniak et al. 2006). 
 
This work constitutes a starting point for the future monitoring studies of resistance 
cassettes dissemination through integrons and also of β-lactamases enzymes in bacteria 
within this environment. It also shows the presence of opportunistic bacteria possessing a 
plethora of antibiotic resistance genes that can be passed to patients compromising the 
treatment of infections caused by these microorganisms. Results also showed the 
percentage of species and resistance genes that were found in this particular 
environment alerting for the implementation of measures to reduce the dissemination of 
bacteria and consequently resistance genes through inanimate surfaces within the 
hospital settings. 
 
 
2. CONCLUSION 
 
According to the main goal of the present work and based on the results obtained it is 
possible to conclude that: 
Inanimate surfaces are colonized by different species of Gram-negative bacteria, 
which carried different resistance determinants.  
 
Furthermore, the results showed:  
. That the prevalence of the class 1 integrons is 33% and β-lactamases enzymes are 
ESBLs, 91% and MBLs, 9%, among the different species; 
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. That the 15 different arrays identified, 47% possess novel gene arrays never 
described before in the specie / worldwide; 53% were already described in 
different countries and species, but in biological samples from patients or animals; 
and 73% were found for the first time in Portugal. 
. That the genes encoding resistance to the aminoglycosides were the most 
frequent (54%).  
. That the resistance to most recently introduced antibiotics is increasing, namely 
to the carbapenems (7% VIM; and 2% IMP) 
. That ESBL enzymes, mainly TEM (66%) and SHV (16%), were the most prevalent.  
 
These results suggest that precautions should be taken to prevent the dissemination 
of these resistance determinants within this selective environment. The implementation 
of simple measures, such as regular disinfection of the surfaces combined with periodic 
surveillance control, will certainly contribute to avoid the dissemination of these bacteria 
among hospitalized patients.      
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Appendix 1 
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Introduction
In a hospital environment, arising of antibiotic resistant strains is not only confined to the
patients but they can also colonize/survive in the surrounding environment. We investigated
the presence of antibiotic resistance mobile elements, such as class 1 integrons in bacterial
strains collected in a hospital female ward sanitary facility.
Methods
 Sterile swabs were rubbed in various sanitary facility surfaces and placed in rich medium
(TSB); after incubation (37ºC-18 h) serial dilutions were inoculated in MacConkey agar and
incubated (37ºC-18 h). Phenotypically different colonies were selected and their clonal
relationship was evaluated by Box-PCR.
 Identification to the species level and antibiotic susceptibilities were determined using the
automatic VITEK2 system and Advanced Expert System (VITEK2 AES) (BioMérieux, Marcy
L´Étoile, France).
 Presence and characterization Class 1 integron was done by PCR followed by nucleotide
sequencing. Nucleotide and deduced aminoacid sequences were analyzed with Blast and
ClustalW programs.
Results
 82 genetically different strains were identified, belonging to the following genera:
Acinetobacter, Alcaligenes, Citrobacter, Escherichia, Enterobacter, Klebsiella, Morganella,
Pseudomonas, Proteus, Serratia and Stenotrophomonas.
 Class 1 integrons were amplified from 24% of the isolates and 17 different gene arrays were
identified. 35% of these arrays contained novel combinations of gene cassette and 41% were
described for the first time in the specie.
 aacA4 was the most abundant gene identified, followed by aadA1 and aadA2. dhfr, blaPSE-1,
arr-3, catB3, ORF and tnpA were also detected, but at lower rates
 blaIMP-8 and blaVIM-2 genes were found exclusively in Pseudomonas spp.
 tniC-containing integrons were identified in a P. putida isolate.
Conclusions
 Class 1 integrons are widely distributed among opportunistic strains examined in this study.
 New integrons containing new gene cassette arrays were found.
 This is the first description of a tniC-containing integron in Portugal.
 Results suggest that strains harbouring class 1 integrons constitute part of the normal
human flora, that are able to survive in hospital surfaces, constituting a possible source for the
dissemination of antibacterial resistant strains between patients.
Aim
The aim of this study was to investigate the presence of class 1 integrons in
bacterial strains collected in a hospital female ward sanitary facility from Hospital
Infante D. Pedro, Aveiro.
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Occurrence and characterization of class 1 integrons from 
isolates collected in a hospital’s sanitary facility in Aveiro, Portugal
intI1 blaVIM-2 ORF-1 tniC P. putida Ppi(FJ237530)
intI1 aacA4 blaVIM-2 tnpA aac6’-IIc qacE∆ sul1
intI1 aacA7 blaVIM-2 aacA4 qacE∆ sul1aacC1
P. putida PFe
(FJ715942)
P. putida PFn
(FJ548856)
intI1 tnpAblaIMP-8 aacA4 qacE∆ sul1aadA1 P. mendocina(FJ594416)
Figure 1: (A) Number of
isolates from each genera
collected for this study;
(B) Number of class 1
integrons found in each
genera; (C) Number of new
gene cassette arrays
identified in this study.
Figure 2: Schematic structure
of some of new gene cassette
arrays identified in
Pseudomonas spp. strains.
Emphasis is given to the first
tnic-like integron found in
Portugal .
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